Vertebrate Trait Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | GWAS889166_H | Human | blood lipid amount | | IAGP | rs429358 | 405850206 | Based on the EFO term ID | GWAS_CATALOG | PMID:35213538 | |
|
Vertebrate Trait Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | GWAS889166_H | Human | blood lipid amount | | IAGP | rs429358 | 405850206 | Based on the EFO term ID | GWAS_CATALOG | PMID:35213538 | |
|
# | Reference Title | Reference Citation |
1. | RGD GWAS Catalog Import Pipeline | RGD pipeline to import data from GWAS Catalog and create human variant and QTL records |
The following Genes overlap with this region. | Full Report | CSV | TAB | Printer | Analysis Tools |
Peak: (rs429358) |
|
The following QTLs overlap with this region. | Full Report | CSV | TAB | Printer | Gviewer |
Data has come from the GWAS Catalog | ||
The highlighted row represents the current QTL |
QTL | GWAS Catalog Study | Disease Trait | Study Size | Risk Allele | Risk Allele Frequency | P Value | P Value MLOG | Peak Marker | Reported Odds Ratio or Beta-coefficient | Ontology Accession | PubMed |
GWAS535687_H | GCST003219 | Advanced age-related macular degeneration | 16,144 European ancestry cases, 17,832 European ancestry controls | ? | NR | 2E-42 | 41.699 | rs429358 | 1.4285715 | atrophic macular degeneration (EFO:1001492) age-related macular degeneration (EFO:0001365) wet macular degeneration (EFO:0004683) |
PMID:26691988 |
GWAS535775_H | GCST003073 | Cerebral amyloid deposition (PET imaging) | up to 883 European and other ancestry individuals | T | 0.02 | 8E-32 | 31.097 | rs429358 | 0.13 | cerebral amyloid deposition measurement (EFO:0007707) |
PMID:26252872 |
GWAS536987_H | GCST003077 | Cerebral amyloid deposition positivity (PET imaging) | up to 350 European and other ancestry positive individuals, up to 296 European and other ancestry negative individuals | C | 0.85 | 5E-20 | 19.302 | rs429358 | 4.72 | cerebral amyloid deposition measurement (EFO:0007707) |
PMID:26252872 |
GWAS541404_H | GCST005515 | Neuritic plaques or cerebral amyloid angiopathy (pleiotropy) | 3,135 European ancestry Alzheimer's disease cases, 463 European ancestry controls | ? | NR | 5E-40 | 39.302 | rs429358 | N/A | neuritic plaque measurement (EFO:0006798) cerebral amyloid angiopathy (EFO:0006790) |
PMID:29458411 |
GWAS541406_H | GCST005517 | Neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy) | 3,135 European ancestry Alzheimer's diseases cases, 463 European ancestry controls | ? | NR | 6E-35 | 34.222 | rs429358 | N/A | cerebral amyloid angiopathy (EFO:0006790) neurofibrillary tangles measurement (EFO:0006797) |
PMID:29458411 |
GWAS541926_H | GCST005516 | Neuritic plaques or neurofibrillary tangles (pleiotropy) | 3,135 European ancestry Alzheimer's disease cases, 463 European ancestry controls | ? | NR | 3E-47 | 46.523 | rs429358 | N/A | neuritic plaque measurement (EFO:0006798) neurofibrillary tangles measurement (EFO:0006797) |
PMID:29458411 |
GWAS547961_H | GCST004603 | Platelet count | 166,066 European ancestry individuals | C | 0.1415 | 3E-9 | 8.523 | rs429358 | 0.0301972 | platelet count (EFO:0004309) |
PMID:27863252 |
GWAS555509_H | GCST007141 | Low density lipoprotein cholesterol levels | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | T | 0.868 | 2E-164 | 163.699 | rs429358 | 0.199 | low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:29507422 |
GWAS555510_H | GCST007141 | Low density lipoprotein cholesterol levels | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | T | 0.885 | 5E-15 | 14.302 | rs429358 | 0.186 | low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:29507422 |
GWAS555511_H | GCST007141 | Low density lipoprotein cholesterol levels | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | T | 0.905 | 2E-7 | 6.699 | rs429358 | 0.152 | low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:29507422 |
GWAS555888_H | GCST007141 | Low density lipoprotein cholesterol levels | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | T | 0.789 | 0.000002 | 5.699 | rs429358 | 0.151 | low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:29507422 |
GWAS555892_H | GCST007141 | Low density lipoprotein cholesterol levels | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | T | NR | 3E-187 | 186.523 | rs429358 | 0.193 | low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:29507422 |
GWAS556499_H | GCST007142 | Triglycerides | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | T | NR | 1E-39 | 39 | rs429358 | 0.077 | triglyceride measurement (EFO:0004530) |
PMID:29507422 |
GWAS556911_H | GCST007142 | Triglycerides | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | T | 0.868 | 9E-34 | 33.046 | rs429358 | 0.078 | triglyceride measurement (EFO:0004530) |
PMID:29507422 |
GWAS556912_H | GCST007142 | Triglycerides | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | T | 0.905 | 0.000001 | 6 | rs429358 | 0.129 | triglyceride measurement (EFO:0004530) |
PMID:29507422 |
GWAS558290_H | GCST007143 | Total cholesterol levels | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | T | 0.905 | 3E-8 | 7.523 | rs429358 | 0.162 | total cholesterol measurement (EFO:0004574) |
PMID:29507422 |
GWAS558292_H | GCST007143 | Total cholesterol levels | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | T | NR | 1E-145 | 145 | rs429358 | 0.167 | total cholesterol measurement (EFO:0004574) |
PMID:29507422 |
GWAS559096_H | GCST007143 | Total cholesterol levels | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | T | 0.868 | 1E-123 | 123 | rs429358 | 0.168 | total cholesterol measurement (EFO:0004574) |
PMID:29507422 |
GWAS559098_H | GCST007143 | Total cholesterol levels | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | T | 0.885 | 3E-14 | 13.523 | rs429358 | 0.18 | total cholesterol measurement (EFO:0004574) |
PMID:29507422 |
GWAS564754_H | GCST007140 | High density lipoprotein cholesterol levels | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | T | NR | 3E-50 | 49.523 | rs429358 | 0.08 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:29507422 |
GWAS565444_H | GCST007140 | High density lipoprotein cholesterol levels | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | T | 0.868 | 6E-47 | 46.222 | rs429358 | 0.084 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:29507422 |
GWAS604065_H | GCST008599 | Longevity (age >99th survival percentile) | 3,484 European ancestry cases, 25,483 European ancestry controls | T | 0.87 | 4E-34 | 33.398 | rs429358 | 1.92 | longevity (EFO:0004300) |
PMID:31413261 |
GWAS604748_H | GCST008598 | Longevity (age >90th survival percentile) | 11,262 European ancestry cases, 25,483 European ancestry controls | T | 0.87 | 1E-56 | 56 | rs429358 | 1.67 | longevity (EFO:0004300) |
PMID:31413261 |
GWAS604750_H | GCST008601 | Longevity (age >99th survival percentile) | 3,484 European ancestry cases, 2,178 East Asian ancestry cases, 25,483 European ancestry controls, 2,299 East Asian ancestry controls | T | 0.87 | 1E-36 | 36 | rs429358 | 1.8181818 | longevity (EFO:0004300) |
PMID:31413261 |
GWAS604754_H | GCST008600 | Longevity (age >90th survival percentile) | 11,262 European ancestry cases, 2,178 East Asian ancestry cases, 177 African American cases, 25,483 European ancestry controls, 2,299 East Asian ancestry controls, 211 African American controls. | T | 0.87 | 1E-61 | 61 | rs429358 | 1.6666665 | longevity (EFO:0004300) |
PMID:31413261 |
None Available | GCST004621 | Red cell distribution width | 171,529 European ancestry individuals | C | 0.1416 | 8E-26 | 25.097 | rs429358 | 0.05202347 | Red cell distribution width (EFO:0009188) |
PMID:27863252 |
GWAS619330_H | GCST008550 | Mental health study participation (completed survey) | 122,647 British ancestry cases, 248,781 British ancestry controls | C | 0.15 | 5E-19 | 18.302 | rs429358 | 0.013306 | health study participation (EFO:0010130) |
PMID:31263887 |
GWAS639722_H | GCST009858 | Waist-to-hip ratio adjusted for BMI | 457,690 European ancestry individuals | ? | NR | 3E-19 | 18.523 | rs429358 | N/A | BMI-adjusted waist-hip ratio (EFO:0007788) |
PMID:31669095 |
GWAS648983_H | GCST009497 | Alzheimer's disease (onset at age over 80) | 2,399 European ancestry cases, 4,160 European ancestry controls | C | 0.126 | 4E-43 | 42.398 | rs429358 | 2.39 | PMID:30979435 | |
GWAS649326_H | GCST009496 | Alzheimer's disease (onset between ages 58 and 79) | 7,316 European ancestry cases, 7,579 European ancestry controls | C | 0.248 | 5E-286 | 285.302 | rs429358 | 3.93 | PMID:30979435 | |
GWAS655841_H | GCST007988 | Insomnia | 651,923 European ancestry males, 679,087 European ancestry females | T | 0.8458 | 2E-8 | 7.699 | rs429358 | 1.047 | insomnia measurement (EFO:0007876) |
PMID:30804565 |
GWAS662907_H | GCST006004 | Low density lipoprotein cholesterol levels | 72,866 Japanese ancestry individuals | ? | NR | 4E-71 | 70.398 | rs429358 | 0.1558 | low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:29403010 |
GWAS665415_H | GCST006012 | C-reactive protein levels | 75,391 Japanese ancestry individuals | ? | NR | 7E-36 | 35.155 | rs429358 | 0.1086 | C-reactive protein measurement (EFO:0004458) |
PMID:29403010 |
GWAS666451_H | GCST005078 | Mortality | 138,536 British ancestry mothers, 133,545 British ancestry fathers | C | NR | 1E-20 | 20 | rs429358 | 1.107 | mortality (EFO:0004352) |
PMID:27029810 |
GWAS681494_H | GCST004983 | Parental lifespan | up to 586,626 European ancestry individuals, up to 19,433 African ancestry individuals | C | 0.142 | 1E-27 | 27 | rs429358 | 0.9 | parental longevity (EFO:0007796) |
PMID:29030599 |
GWAS681495_H | GCST005276 | Dementia with Lewy bodies | 1,216 European ancestry cases, 3,791 European ancestry controls | C | 0.14 | 3E-64 | 63.523 | rs429358 | 2.46 | Lewy body dementia (EFO:0006792) |
PMID:29263008 |
GWAS685111_H | GCST006005 | High density lipoprotein cholesterol levels | 70,657 Japanese ancestry individuals | ? | NR | 2E-24 | 23.699 | rs429358 | 0.08948 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:29403010 |
GWAS685577_H | GCST006034 | Total cholesterol levels | 128,305 Japanese ancestry individuals | ? | NR | 2E-57 | 56.699 | rs429358 | 0.1052 | total cholesterol measurement (EFO:0004574) |
PMID:29403010 |
GWAS687468_H | GCST008998 | Waist-hip ratio | 316,772 European ancestry male individuals | T | 0.8459 | 4E-37 | 36.398 | rs429358 | 0.0346 | waist-hip ratio (EFO:0004343) |
PMID:30239722 |
GWAS702295_H | GCST006098 | Vigorous physical activity | 98,060 European ancestry active cases, 162,995 European ancestry inactive controls | C | NR | 5E-7 | 6.302 | rs429358 | N/A | physical activity measurement (EFO:0008002) |
PMID:29899525 |
GWAS704575_H | GCST006097 | Moderate to vigorous physical activity levels | 377,234 European ancestry individuals | T | 0.85 | 6E-13 | 12.222 | rs429358 | 0.022 | physical activity measurement (EFO:0008002) |
PMID:29899525 |
None Available | GCST008829 | Neuritic plaque | 2,701 European ancestry men, 3,275 European ancestry women | C | 0.258405 | 5E-20 | 19.302 | rs429358 | 1.113172 | neuritic plaque measurement (EFO:0006798) |
PMID:31497858 |
GWAS715521_H | GCST008830 | Neurofibrillary tangles | 3,275 European ancestry women | C | 0.263094 | 5E-23 | 22.302 | rs429358 | 1.257302 | neurofibrillary tangles measurement (EFO:0006797) |
PMID:31497858 |
GWAS717084_H | GCST008822 | Neuritic plaque | 2,701 European ancestry men | C | 0.258035 | 9E-25 | 24.046 | rs429358 | 1.232879 | neuritic plaque measurement (EFO:0006798) |
PMID:31497858 |
GWAS717096_H | GCST008821 | Neurofibrillary tangles | 2,701 European ancestry men | C | 0.260771 | 3E-31 | 30.523 | rs429358 | 1.500561 | neurofibrillary tangles measurement (EFO:0006797) |
PMID:31497858 |
GWAS717173_H | GCST008437 | Alzheimer's disease in hypertension-negative individuals | 796 European ancestry cases, 4,010 European ancestry controls | ? | 0.210 | 2E-30 | 29.699 | rs429358 | 5.24 | PMID:31055733 | |
GWAS717180_H | GCST008438 | Alzheimer's disease in hypertension | 1,262 European ancestry cases, 9,608 European ancestry controls | ? | 0.147 | 6E-43 | 42.222 | rs429358 | 3.26 | PMID:31055733 | |
None Available | GCST008996 | Waist-hip ratio | 697,734 European ancestry individuals | T | 0.8459 | 4E-37 | 36.398 | rs429358 | 0.0346 | waist-hip ratio (EFO:0004343) |
PMID:30239722 |
GWAS717989_H | GCST009020 | Alzheimer's disease | 4,120 European ancestry cases, 3,289 European ancestry controls | C | 0.17 | 1E-62 | 62 | rs429358 | 2.27 | PMID:31473137 | |
GWAS717990_H | GCST009025 | Alzheimer’s disease and/or vascular dementia (clinical subgroup VaD+) | 1,168 Spanish ancestry cases, 3,289 Spanish ancestry controls | C | 0.17 | 6E-14 | 13.222 | rs429358 | 1.69 | PMID:31473137 | |
GWAS717991_H | GCST009022 | Alzheimer’s disease (clinical subgroup AD+) | 3,797 Spanish ancestry cases, 3,289 Spanish ancestry controls | C | 0.17 | 1E-64 | 64 | rs429358 | 2.39 | PMID:31473137 | |
GWAS717992_H | GCST009023 | Alzheimer’s disease (clinical subgroup AD++) | 2,611 Spanish ancestry cases, 3,289 Spanish ancestry controls | C | 0.17 | 1E-76 | 76 | rs429358 | 2.71 | PMID:31473137 | |
GWAS718234_H | GCST009024 | Alzheimer’s disease (clinical subgroup AD+++) | 1,854 Spanish ancestry cases, 3,289 Spanish ancestry controls | C | 0.17 | 1E-75 | 75 | rs429358 | 2.92 | PMID:31473137 | |
GWAS718238_H | GCST009019 | Alzheimer's disease | 4,120 Spanish ancestry cases, 11,999 cases, 3,289 Spanish ancestry controls, 9,236 controls | ? | NR | 2E-303 | 302.699 | rs429358 | 3.21 | PMID:31473137 | |
GWAS718994_H | GCST003901 | Cognitive decline (age-related) | 3,964 African American ancestry individuals. | ? | NR | 2E-14 | 13.699 | rs429358 | 0.01 | Mental deterioration (HP:0001268) |
PMID:28078323 |
GWAS719658_H | GCST007001 | Cerebrospinal AB1-42 levels in normal cognition | 305 European ancestry cognitively normal individuals | C | 0.25 | 9E-11 | 10.046 | rs429358 | 0.84 | beta-amyloid 1-42 measurement (EFO:0004670) |
PMID:29274321 |
GWAS719670_H | GCST007012 | Cerebrospinal fluid AB1-42 levels | 305 European ancestry cognitively normal individuals, 581 European ancestry mild cognitive impairment cases, 190 European ancestry Alzheimer's disease dementia cases | C | 0.25 | 1E-51 | 51 | rs429358 | 0.8 | beta-amyloid 1-42 measurement (EFO:0004670) |
PMID:29274321 |
None Available | GCST007007 | Cerebrospinal fluid t-tau levels | 305 European ancestry cognitively normal individuals, 581 European ancestry mild cognitive impairment cases, 190 European ancestry Alzheimer's disease dementia cases | C | 0.25 | 1E-20 | 20 | rs429358 | 0.55 | t-tau measurement (EFO:0004760) |
PMID:29274321 |
GWAS719858_H | GCST007008 | Cerebrospinal fluid p-tau levels | 305 European ancestry cognitively normal individuals, 581 European ancestry mild cognitive impairment cases, 190 European ancestry Alzheimer's disease dementia cases | C | 0.25 | 3E-18 | 17.523 | rs429358 | 0.51 | p-tau measurement (EFO:0004763) |
PMID:29274321 |
GWAS719866_H | GCST007009 | Hippocampal volume | 305 European ancestry cognitively normal individuals, 581 European ancestry mild cognitive impairment cases, 190 European ancestry Alzheimer's disease dementia cases | C | 0.25 | 2E-19 | 18.699 | rs429358 | 0.47 | hippocampal volume (EFO:0005035) |
PMID:29274321 |
GWAS719872_H | GCST007011 | Logical memory (immediate recall) | 305 European ancestry cognitively normal individuals, 581 European ancestry mild cognitive impairment cases, 190 European ancestry Alzheimer's disease dementia cases | C | 0.25 | 2E-13 | 12.699 | rs429358 | 0.36 | memory performance (EFO:0004874) |
PMID:29274321 |
GWAS721792_H | GCST006701 | Parental longevity (father's attained age) | 415,311 British ancestry individuals | T | NR | 2E-28 | 27.699 | rs429358 | N/A | parental longevity (EFO:0007796) |
PMID:29227965 |
GWAS721797_H | GCST006702 | Parental longevity (combined parental age at death) | 208,118 British ancestry individuals | T | 0.842077 | 5E-22 | 21.302 | rs429358 | 0.0436 | parental longevity (EFO:0007796) |
PMID:29227965 |
GWAS721958_H | GCST006698 | Parental longevity (both parents in top 10%) | 7,182 cases, 79,767 controls | T | 0.842 | 7E-46 | 45.155 | rs429358 | 0.0388 | parental longevity (EFO:0007796) |
PMID:29227965 |
GWAS721961_H | GCST006699 | Parental longevity (mother's age at death) | 246,941 British ancestry individuals | T | 0.842 | 7E-19 | 18.155 | rs429358 | 0.0336 | parental longevity (EFO:0007796) |
PMID:29227965 |
GWAS721963_H | GCST006697 | Parental longevity (combined parental attained age, Martingale residuals) | 389,166 British ancestry individuals | T | 0.845 | 1E-74 | 74 | rs429358 | 0.0566 | parental longevity (EFO:0007796) |
PMID:29227965 |
GWAS722161_H | GCST006700 | Parental longevity (father's age at death) | 317,652 British ancestry individuals | T | 0.842 | 9E-13 | 12.046 | rs429358 | 0.0262 | parental longevity (EFO:0007796) |
PMID:29227965 |
GWAS722171_H | GCST006696 | Parental longevity (mother's attained age) | 412,937 British ancestry individuals | T | NR | 1E-68 | 68 | rs429358 | N/A | parental longevity (EFO:0007796) |
PMID:29227965 |
GWAS722188_H | GCST006996 | Cerebrospinal AB1-42 levels in mild cognitive impairment | 581 European ancestry MCI dementia cases | C | 0.25 | 6E-27 | 26.222 | rs429358 | 0.77 | beta-amyloid 1-42 measurement (EFO:0004670) |
PMID:29274321 |
GWAS722189_H | GCST006997 | Cerebrospinal fluid t-tau levels in mild cognitive impairment | 581 European ancestry cases | C | 0.25 | 1E-13 | 13 | rs429358 | 0.57 | t-tau measurement (EFO:0004760) |
PMID:29274321 |
GWAS722390_H | GCST006998 | Cerebrospinal fluid p-tau levels in mild cognitive impairment | 581 European ancestry mild cognitive impairment cases | C | 0.25 | 2E-11 | 10.699 | rs429358 | 0.53 | t-tau measurement (EFO:0004760) |
PMID:29274321 |
GWAS722651_H | GCST010496 | Relative sugar intake | 175,253 European ancestry individuals | ? | NR | 3E-11 | 10.523 | rs429358 | 0.028 | sugar consumption measurement (EFO:0010158) |
PMID:32393786 |
GWAS722730_H | GCST007010 | Logical memory (delayed recall) | 305 European ancestry cognitively normal individuals, 581 European ancestry mild cognitive impairment cases, 190 European ancestry Alzheimer's disease dementia cases | C | 0.25 | 2E-18 | 17.699 | rs429358 | 0.42 | memory performance (EFO:0004874) |
PMID:29274321 |
GWAS731563_H | GCST009441 | Age-related cognitive decline (memory) (slope of z-scores) | 1,145 European ancestry individuals | C | 0.1 | 0.000007 | 5.155 | rs429358 | 0.29 | cognitive decline measurement (EFO:0007710) |
PMID:30954325 |
GWAS732620_H | GCST008740 | Hyperopia | 361 European ancestry cases, 1,700 European ancestry controls | C | NR | 1E-7 | 7 | rs429358 | 1.77 | PMID:30098192 | |
GWAS733778_H | GCST009449 | Parental longevity (mother's age at death or mother's attained age) | up to 699,000 individuals | T | NR | 4E-57 | 56.398 | rs429358 | N/A | parental longevity (EFO:0007796) |
PMID:31484785 |
GWAS736382_H | GCST010242 | HDL cholesterol levels | 403,943 European ancestry individuals | T | 0.845675 | 7E-180 | 179.155 | rs429358 | 0.0754686 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:32203549 |
GWAS736930_H | GCST010241 | Apolipoprotein A1 levels | 393,193 European ancestry individuals | T | 0.845522 | 8E-311 | 310.097 | rs429358 | 0.102369 | apolipoprotein A 1 measurement (EFO:0004614) |
PMID:32203549 |
GWAS737522_H | GCST010143 | Meat-related diet | 154,123 European ancestry men, 181,453 European ancestry women | ? | NR | 5E-13 | 12.302 | rs429358 | 0.0242948 | diet measurement (EFO:0008111) |
PMID:32066663 |
GWAS738098_H | GCST010143 | Meat-related diet | 154,123 European ancestry men, 181,453 European ancestry women | ? | NR | 1E-8 | 8 | rs429358 | 0.0261231 | diet measurement (EFO:0008111) |
PMID:32066663 |
None Available | GCST009367 | HDL cholesterol levels x short total sleep time interaction (2df test) | 3,007 African American short sleepers, 369 Chinese ancestry short sleepers, 114 Asian ancestry short sleepers, at least 8,474 European ancestry short sleepers, 1,082 Hispanic/Latino short sleepers, up to 11,901 African American controls, 1,444 Chinese ancestry controls, 452 Asian ancestry controls, at least 31,567 European ancestry controls, 4,047 Hispanic/Latino controls | ? | NR | 4E-37 | 36.398 | rs429358 | 0.0204 | sleep duration (EFO:0005271) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:31719535 |
GWAS742508_H | GCST010378 | Spherical equivalent | 95,827 European ancestry individuals | C | NR | 4E-8 | 7.398 | rs429358 | 0.09 | PMID:32352494 | |
None Available | GCST009379 | Type 2 diabetes | 74,124 European ancestry cases, 824,006 European ancestry controls | T | 0.8458 | 3E-18 | 17.523 | rs429358 | 1.08 | PMID:30297969 | |
GWAS743168_H | GCST010133 | Lamb consumption | 335,576 European ancestry individuals | ? | NR | 5E-12 | 11.302 | rs429358 | 0.0232225 | diet measurement (EFO:0008111) |
PMID:32066663 |
GWAS743341_H | GCST009777 | C-reactive protein levels | 418,642 British ancestry individuals | T | 0.8442 | 2E-1953 | 1952.699 | rs429358 | 0.26396 | C-reactive protein measurement (EFO:0004458) |
PMID:31900758 |
GWAS743453_H | GCST010002 | Refractive error | 542,934 European ancestry individuals | ? | NR | 3E-17 | 16.523 | rs429358 | N/A | Abnormality of refraction (HP:0000539) |
PMID:32231278 |
GWAS743791_H | GCST007067 | Waist-hip ratio | approximately 458,000 European ancestry individuals | ? | NR | 4E-18 | 17.398 | rs429358 | N/A | waist-hip ratio (EFO:0004343) |
PMID:30595370 |
None Available | GCST90449025 | Vascular dementia | 3,892 European ancestry cases, 466,606 European ancestry controls | C | 0.1549 | 3E-196 | 195.523 | rs429358 | 0.8794 | PMID:39046104 | |
None Available | GCST90012827 | Diffuse plaques | 909 European ancestry individuals | T | 0.86 | 1E-20 | 20 | rs429358 | N/A | diffuse plaque measurement (EFO:0010699) |
PMID:28322283 |
GWAS746223_H | GCST90012832 | Neuropathologic traits (pleiotropy) | 909 European ancestry individuals | T | 0.85 | 3E-33 | 32.523 | rs429358 | N/A | brain infarction (EFO:0004277) neuritic plaque measurement (EFO:0006798) Lewy body dementia (EFO:0006792) cerebral amyloid angiopathy (EFO:0006790) More... |
PMID:28322283 |
GWAS746227_H | GCST90012828 | Cerebral amyloid angiopathy | 404 European ancestry mild cases, 209 European ancestry moderate cases, 113 European ancestry severe cases, 183 European ancestry controls | T | 0.86 | 5E-25 | 24.302 | rs429358 | N/A | cerebral amyloid angiopathy (EFO:0006790) |
PMID:28322283 |
GWAS746232_H | GCST90012825 | Neuritic plaque | 909 European ancestry individuals | T | 0.86 | 3E-24 | 23.523 | rs429358 | N/A | neuritic plaque measurement (EFO:0006798) |
PMID:28322283 |
GWAS746234_H | GCST90012826 | Neurofibrillary tangles | 909 European ancestry individuals | T | 0.85 | 4E-20 | 19.398 | rs429358 | 0.27 | neurofibrillary tangles measurement (EFO:0006797) |
PMID:28322283 |
GWAS747383_H | GCST010101 | White matter hyperintensities | 39,011 European ancestry individuals, 2,099 African ancestry individuals, 795 Hispanic individuals, 3,299 Asian ancestry individuals | T | NR | 1E-9 | 9 | rs429358 | 6.061 | white matter hyperintensity measurement (EFO:0005665) |
PMID:32358547 |
None Available | GCST90309350 | Coronary artery disease (confirmatory factor analysis Factor 16) | 360,021 European ancestry individuals | ? | NR | 4E-43 | 42.398 | rs429358 | N/A | coronary artery disease (EFO:0001645) |
PMID:38965376 |
None Available | GCST90091033 | Nonalcoholic fatty liver disease | 8,434 European ancestry cases, 770,180 European ancestry controls | C | NR | 1E-8 | 8 | rs429358 | 0.1366 | non-alcoholic fatty liver disease (EFO:0003095) |
PMID:34841290 |
None Available | GCST90449024 | Dementia | 44,009 European ancestry cases, 466,606 European ancestry controls | C | 0.1515 | 7E-305 | 304.155 | rs429358 | 1.1728 | PMID:39046104 | |
None Available | GCST002531 | Cerebrospinal AB1-42 levels in Alzheimer's disease dementia | 363 European ancestry individuals | ? | 0.442 | 4E-17 | 16.398 | rs429358 | 0.4 | beta-amyloid 1-42 measurement (EFO:0004670) |
PMID:25027320 |
None Available | GCST002591 | Lewy body disease | up to 3,526 individuals | C | 0.7347 | 5E-12 | 11.302 | rs429358 | 0.508 | Lewy body dementia (EFO:0006792) Lewy body dementia measurement (EFO:0006799) |
PMID:25188341 |
None Available | GCST002591 | Lewy body disease | up to 3,526 individuals | C | 0.7344 | 3E-11 | 10.523 | rs429358 | 0.4905 | Lewy body dementia (EFO:0006792) Lewy body dementia measurement (EFO:0006799) |
PMID:25188341 |
None Available | GCST002591 | Lewy body disease | up to 3,526 individuals | C | 0.732 | 1E-12 | 12 | rs429358 | 0.4997 | Lewy body dementia (EFO:0006792) Lewy body dementia measurement (EFO:0006799) |
PMID:25188341 |
GWAS772076_H | GCST002899 | HDL cholesterol | up to 62,166 European ancestry individuals | T | 0.84 | 1E-14 | 14 | rs429358 | 0.066 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:25961943 |
None Available | GCST000900 | Alzheimer's disease biomarkers | 96 European ancestry Alzheimer disease cases, 176 European ancestry individuals with mild cognitive impairment, 102 European ancestry controls | ? | NR | 0.000001 | 6 | rs429358 | N/A | p-tau measurement (EFO:0004763) beta-amyloid 1-42 measurement (EFO:0004670) t-tau measurement (EFO:0004760) |
PMID:21123754 |
None Available | GCST000573 | Brain imaging | 175 European ancestry Alzheimer cases, 354 European ancestry amnestic mild cognitive impairment cases, 204 European ancestry controls | ? | NR | 1E-7 | 7 | rs429358 | N/A | neuroimaging measurement (EFO:0004346) |
PMID:20100581 |
None Available | GCST000573 | Brain imaging | 175 European ancestry Alzheimer cases, 354 European ancestry amnestic mild cognitive impairment cases, 204 European ancestry controls | ? | NR | 1E-9 | 9 | rs429358 | N/A | neuroimaging measurement (EFO:0004346) |
PMID:20100581 |
GWAS792381_H | GCST011583 | Serum C-reactive protein concentration | 10,798 European ancestry women | ? | NR | 8E-10 | 9.097 | rs429358 | 0.76 | C-reactive protein measurement (EFO:0004458) |
PMID:32928877 |
None Available | GCST010557 | Type 2 diabetes | 148,726 European ancestry cases, 24,646 African American cases, 8,616 Hispanic cases, 46,511 Asian ancestry cases, 965,732 European ancestry controls, 31,446 African American controls, 11,829 Hispanic controls, 169,776 Asian ancestry controls | C | 0.1469 | 2E-26 | 25.699 | rs429358 | 0.0585 | PMID:32541925 | |
GWAS796834_H | GCST011365 | Myocardial infarction | 14,825 European ancestry cases, 44,000 European and unknown ancestry cases, 2,680 cases, 380,970 European ancestry controls, 123,504 European and unknown ancestry controls, 73,242 controls | C | 0.139064 | 4E-22 | 21.398 | rs429358 | 1.11 | myocardial infarction (EFO:0000612) |
PMID:33532862 |
GWAS797930_H | GCST010555 | Type 2 diabetes | 148,726 European ancestry cases, 965,732 European ancestry controls | C | 0.1454 | 4E-28 | 27.398 | rs429358 | 0.073 | PMID:32541925 | |
GWAS798437_H | GCST90002397 | Mean spheric corpuscular volume | 408,112 British individuals | C | 0.154528 | 2E-46 | 45.699 | rs429358 | 0.044340204 | mean corpuscular volume (EFO:0004526) |
PMID:32888494 |
None Available | GCST90309357 | Physical activity (confirmatory factor analysis Factor 23) | 354,112 European ancestry individuals | ? | NR | 4E-9 | 8.398 | rs429358 | N/A | physical activity measurement (EFO:0008002) |
PMID:38965376 |
GWAS799403_H | GCST90002400 | Plateletcrit | 408,112 British individuals | C | 0.154526 | 6E-31 | 30.222 | rs429358 | 0.03638729 | platelet crit (EFO:0007985) |
PMID:32888494 |
GWAS799407_H | GCST90011898 | Alanine aminotransferase levels | 390,812 European ancestry individuals | T | 0.84 | 5E-35 | 34.302 | rs429358 | 12.4 | serum alanine aminotransferase measurement (EFO:0004735) |
PMID:33547301 |
GWAS799625_H | GCST011100 | Aging traits (healthspan, parental lifespan or longevity) (multivariate analysis) | at least 837,415 European ancestry individuals | T | 0.8533 | 1E-126 | 126 | rs429358 | N/A | longevity (EFO:0004300) healthspan (EFO:0009762) parental longevity (EFO:0007796) |
PMID:32678081 |
None Available | GCST90309364 | Inflammatory markers and poor diet (confirmatory factor analysis Factor 30) | 337,045 European ancestry individuals | ? | NR | 2E-18 | 17.699 | rs429358 | N/A | inflammatory biomarker measurement (EFO:0004872) diet measurement (EFO:0008111) |
PMID:38965376 |
GWAS809391_H | GCST001868 | Alzheimer's disease biomarkers | 555 European ancestry individuals | C | 0.28 | 5E-14 | 13.302 | rs429358 | N/A | amyloid-beta measurement (EFO:0005194) |
PMID:23419831 |
GWAS813293_H | GCST90012877 | Alzheimer's disease or family history of Alzheimer's disease | 472,868 European ancestry individuals | ? | NR | 1E-300 | 300 | rs429358 | 1.17924 | family history of Alzheimer’s disease (EFO:0009268) |
PMID:33589840 |
GWAS813296_H | GCST90013665 | Alzheimer's disease | 212 European ancestry cases, 333 European ancestry controls | C | 0.2968 | 3E-7 | 6.523 | rs429358 | 2.256 | PMID:33223526 | |
GWAS813298_H | GCST90013667 | Amyloid status (abnormal vs normal) | 455 European ancestry cases, 416 European ancestry controls | C | 0.2968 | 2E-25 | 24.699 | rs429358 | 5.664 | amyloid-beta measurement (EFO:0005194) |
PMID:33223526 |
GWAS813299_H | GCST90013668 | Central cerebrospinal fluid amyloid beta 42 to 40 ratio (abnormal vs normal) | 418 European ancestry cases, 259 European ancestry controls | C | 0.2968 | 5E-24 | 23.302 | rs429358 | 7.027 | amyloid-beta measurement (EFO:0005194) |
PMID:33223526 |
None Available | GCST90002402 | Platelet count | 408,112 British individuals | C | 0.154533 | 4E-21 | 20.398 | rs429358 | 0.029496036 | platelet count (EFO:0004309) |
PMID:32888494 |
GWAS816041_H | GCST90128558 | Amygdala volume change rate x age interaction (1df) | 15,100 European ancestry individuals | T | 0.839 | 6E-8 | 7.222 | rs429358 | N/A | amygdala volume change measurement (EFO:0021490) age at assessment (EFO:0008007) |
PMID:35383335 |
None Available | GCST90128587 | Total brain volume change rate x age interaction (2df) | 15,100 European ancestry individuals | T | 0.839 | 0.000001 | 6 | rs429358 | N/A | total brain volume change measurement (EFO:0021504) age at assessment (EFO:0008007) |
PMID:35383335 |
GWAS816755_H | GCST90013670 | Amyloid pathology | 890 European ancestry individuals | T | 0.7032 | 4E-33 | 32.398 | rs429358 | 0.573 | amyloid-beta measurement (EFO:0005194) |
PMID:33223526 |
GWAS816771_H | GCST90013671 | Central cerebrospinal fluid amyloid beta 42 levels | 677 European ancestry individuals | T | 0.7032 | 5E-17 | 16.302 | rs429358 | 0.11 | amyloid-beta measurement (EFO:0005194) |
PMID:33223526 |
GWAS816772_H | GCST90013674 | Central cerebrospinal fluid amyloid beta 42 to 40 ratio | 677 European ancestry individuals | T | 0.7032 | 6E-32 | 31.222 | rs429358 | 0.105 | amyloid-beta measurement (EFO:0005194) |
PMID:33223526 |
None Available | GCST90012792 | Acceptance of an invitation to participate in a mental health questionnaire | 146,074 European ancestry cases, 148,713 European ancestry controls | T | 0.85 | 1E-20 | 20 | rs429358 | 1.06 | health study participation (EFO:0010130) |
PMID:33563987 |
None Available | GCST90128580 | Hippocampus volume change rate x age interaction (2df) | 15,100 European ancestry individuals | T | 0.8401 | 2E-8 | 7.699 | rs429358 | N/A | hippocampus volume change measurement (EFO:0021492) age at assessment (EFO:0008007) |
PMID:35383335 |
GWAS820693_H | GCST90128573 | Amygdala volume change rate x age interaction (2df) | 15,100 European ancestry individuals | T | 0.839 | 8E-8 | 7.097 | rs429358 | N/A | amygdala volume change measurement (EFO:0021490) age at assessment (EFO:0008007) |
PMID:35383335 |
None Available | GCST90128592 | Hippocampus volume change rate x age interaction (2df) | 15,100 European ancestry individuals, 490 Mixed ancestry individuals, 50 South African ancestry individuals | T | 0.8401 | 1E-8 | 8 | rs429358 | N/A | hippocampus volume change measurement (EFO:0021492) age at assessment (EFO:0008007) |
PMID:35383335 |
GWAS830059_H | GCST90179150 | Body mass index (MTAG) | 694,649 European ancestry individuals | T | NR | 3E-36 | 35.523 | rs429358 | 0.035985 | body mass index (EFO:0004340) |
PMID:36376304 |
None Available | GCST90246572 | ADP-ribosylation factor-like protein 1 levels | 10,708 European ancestry individuals | T | 0.85 | 4E-17 | 16.398 | rs429358 | 0.151 | ADP-ribosylation factor-like protein 1 measurement (EFO:0801354) |
PMID:34648354 |
None Available | GCST90248843 | Platelet-activating factor acetylhydrolase levels | 10,708 European ancestry individuals | T | 0.85 | 1E-64 | 64 | rs429358 | 0.319 | protein measurement (EFO:0004747) |
PMID:34648354 |
None Available | GCST90247951 | Heparan sulfate glucosamine 3-O-sulfotransferase 5 levels | 10,708 European ancestry individuals | T | 0.85 | 2E-12 | 11.699 | rs429358 | 0.128 | protein measurement (EFO:0004747) |
PMID:34648354 |
GWAS836452_H | GCST90246545 | Apolipoprotein B levels | 10,708 European ancestry individuals | T | 0.85 | 2E-78 | 77.699 | rs429358 | 0.351 | apolipoprotein B measurement (EFO:0004615) |
PMID:34648354 |
GWAS837871_H | GCST90248138 | Integral membrane protein 2B levels | 10,708 European ancestry individuals | T | 0.85 | 8E-16 | 15.097 | rs429358 | 0.151 | integral membrane protein 2B measurement (EFO:0802634) |
PMID:34648354 |
GWAS838263_H | GCST90249151 | Pregnancy-specific beta-1-glycoprotein 5 levels | 10,708 European ancestry individuals | T | 0.85 | 1E-112 | 112 | rs429358 | 0.422 | pregnancy-specific beta-1-glycoprotein 5 measurement (EFO:0801908) |
PMID:34648354 |
GWAS838269_H | GCST90249141 | PH and SEC7 domain-containing protein 1 levels | 10,708 European ancestry individuals | T | 0.85 | 6E-20 | 19.222 | rs429358 | 0.173 | PH and SEC7 domain-containing protein 1 measurement (EFO:0803302) |
PMID:34648354 |
GWAS839283_H | GCST90249308 | Regulator of G-protein signaling 7 levels | 10,708 European ancestry individuals | T | 0.85 | 2E-16 | 15.699 | rs429358 | 0.158 | protein measurement (EFO:0004747) |
PMID:34648354 |
GWAS843452_H | GCST90248017 | Inactive gamma-glutamyltranspeptidase 2 levels | 10,708 European ancestry individuals | T | 0.85 | 4E-225 | 224.398 | rs429358 | 0.577 | inactive gamma-glutamyltranspeptidase 2 measurement (EFO:0801692) |
PMID:34648354 |
None Available | GCST90448667 | Lipoprotein-associated phospholipase A2 activity | 511 Asian ancestry individuals, 1,546 Black individuals, 836 Hispanic or Latin American individuals, 7,317 European ancestry individuals | C | 0.1367 | 4E-37 | 36.398 | rs429358 | 0.064 | lipoprotein-associated phospholipase A(2) measurement (EFO:0004746) |
PMID:38747556 |
GWAS844623_H | GCST90250187 | Vacuolar protein sorting-associated protein 29 levels | 10,708 European ancestry individuals | T | 0.85 | 7E-176 | 175.155 | rs429358 | 0.517 | vacuolar protein sorting-associated protein 29 measurement (EFO:0802207) |
PMID:34648354 |
GWAS844735_H | GCST90249595 | Small nuclear ribonucleoprotein F levels | 10,708 European ancestry individuals | T | 0.85 | 9E-109 | 108.046 | rs429358 | 0.416 | small nuclear ribonucleoprotein F measurement (EFO:0008288) |
PMID:34648354 |
GWAS845545_H | GCST90247165 | C-reactive protein levels | 10,708 European ancestry individuals | T | 0.85 | 4E-32 | 31.398 | rs429358 | 0.225 | C-reactive protein measurement (EFO:0004458) |
PMID:34648354 |
None Available | GCST90247196 | CUB and zona pellucida-like domain-containing protein 1 levels | 10,708 European ancestry individuals | T | 0.85 | 6E-35 | 34.222 | rs429358 | 0.238 | CUB and zona pellucida-like domain-containing protein 1 measurement (EFO:0803309) |
PMID:34648354 |
GWAS846160_H | GCST90247243 | DCN1-like protein 5 levels | 10,708 European ancestry individuals | T | 0.85 | 2E-441 | 440.699 | rs429358 | 0.787 | DCN1-like protein 5 measurement (EFO:0801520) |
PMID:34648354 |
GWAS846846_H | GCST90248334 | Leucine-rich repeat neuronal protein 1 levels | 10,708 European ancestry individuals | T | 0.85 | 8E-1394 | 1393.097 | rs429358 | 1.217 | leucine-rich repeat neuronal protein 1 measurement (EFO:0801760) |
PMID:34648354 |
None Available | GCST90246878 | Carboxypeptidase E levels | 10,708 European ancestry individuals | T | 0.85 | 9E-25 | 24.046 | rs429358 | 0.199 | carboxypeptidase e measurement (EFO:0020234) |
PMID:34648354 |
None Available | GCST90448658 | C-reactive protein levels | 592 Asian ancestry individuals, 8,819 Black individuals, 8,721 Hispanic or Latin American individuals, 20,333 European ancestry individuals | C | 0.1481 | 6E-109 | 108.222 | rs429358 | 0.25 | C-reactive protein measurement (EFO:0004458) |
PMID:38747556 |
None Available | GCST90247157 | Cysteine-rich protein 1 levels | 10,708 European ancestry individuals | T | 0.85 | 4E-26 | 25.398 | rs429358 | 0.198 | protein measurement (EFO:0004747) |
PMID:34648354 |
GWAS850048_H | GCST90179151 | Cigarettes smoked per day (MTAG) | 337,334 European ancestry individuals | T | NR | 1E-18 | 18 | rs429358 | 0.031518 | cigarettes per day measurement (EFO:0006525) |
PMID:36376304 |
GWAS853268_H | GCST90270129 | Parkinson’s disease progression to dementia | 3,923 European ancestry individuals | C | NR | 2E-15 | 14.699 | rs429358 | 2.41 | disease progression measurement (EFO:0008336) |
PMID:36348503 |
GWAS853990_H | GCST90269506 | Triglycerides in LDL (UKB data field 23409) | 88,329 European ancestry individuals | C | 0.155555 | 9E-51 | 50.046 | rs429358 | 0.096245 | triglycerides in LDL measurement (EFO:0022320) |
PMID:36764567 |
GWAS856676_H | GCST90249978 | tRNA (guanine-N(7)-)-methyltransferase levels | 10,708 European ancestry individuals | T | 0.85 | 3E-75 | 74.523 | rs429358 | 0.342 | tRNA (guanine-N(7)-)-methyltransferase measurement (EFO:0802162) |
PMID:34648354 |
GWAS856932_H | GCST90249769 | Tubulin-specific chaperone A levels | 10,708 European ancestry individuals | T | 0.85 | 2E-1609 | 1608.699 | rs429358 | 1.256 | tubulin-specific chaperone A measurement (EFO:0802166) |
PMID:34648354 |
None Available | GCST90249737 | Surfeit locus protein 1 levels | 10,708 European ancestry individuals | T | 0.85 | 1E-18 | 18 | rs429358 | 0.169 | surfeit locus protein 1 measurement (EFO:0802105) |
PMID:34648354 |
None Available | GCST90248651 | Neutrophil collagenase levels | 10,708 European ancestry individuals | T | 0.85 | 1E-62 | 62 | rs429358 | 0.319 | neutrophil collagenase measurement (EFO:0008248) |
PMID:34648354 |
GWAS859024_H | GCST90248753 | Nucleosome-remodeling factor subunit BPTF levels | 10,708 European ancestry individuals | T | 0.85 | 6E-49 | 48.222 | rs429358 | 0.281 | protein measurement (EFO:0004747) |
PMID:34648354 |
None Available | GCST90274865 | Obstructive sleep apnea | 23,651 black cases, 84,817 black controls, 1,720 Asian ancestry cases, 6,361 Asian ancestry controls, 117,496 European ancestry cases, 635,463 European ancestry controls, 11,056 Hispanic or Latin American cases, 34,840 Hispanic or Latin American controls, 130 cases, 1,162 controls | ? | 0.192886 | 5E-11 | 10.302 | rs429358 | 0.959817 | obstructive sleep apnea (EFO:0003918) |
PMID:36989840 |
GWAS859633_H | GCST90250009 | Tumor protein p53-inducible protein 11 levels | 10,708 European ancestry individuals | T | 0.85 | 2E-228 | 227.699 | rs429358 | 0.582 | tumor protein p53-inducible protein 11 measurement (EFO:0802169) |
PMID:34648354 |
GWAS860170_H | GCST90275066 | C-reactive protein levels | 47,258 Korean ancestry individuals | C | 0.096 | 4E-125 | 124.398 | rs429358 | 0.321 | C-reactive protein measurement (EFO:0004458) |
PMID:36996866 |
None Available | GCST90301368 | Age of onset of ischemic stroke | 10,857 European ancestry individuals | C | 0.16 | 0.000001 | 6 | rs429358 | 0.88 | PMID:39286457 | |
None Available | GCST90301370 | Age of onset of ischemic stroke | 4,679 European ancestry females | C | 0.14 | 2E-11 | 10.699 | rs429358 | 1.29 | PMID:39286457 | |
GWAS861600_H | GCST90249920 | Transmembrane and coiled-coil domains protein 3 levels | 10,708 European ancestry individuals | T | 0.85 | 1E-181 | 181 | rs429358 | 0.527 | protein measurement (EFO:0004747) |
PMID:34648354 |
None Available | GCST90264174 | Intelligence | 223,731 British ancestry individuals | ? | NR | 4E-18 | 17.398 | rs429358 | N/A | intelligence (EFO:0004337) |
PMID:36378351 |
None Available | GCST90269571 | 3-hydroxybutyrate levels (UKB data field 23474) | 87,151 European ancestry individuals | C | 0.155644 | 4E-19 | 18.398 | rs429358 | 0.0584598 | 3-hydroxybutyrate measurement (EFO:0010982) |
PMID:36764567 |
GWAS865232_H | GCST90248673 | Neurofilament light polypeptide levels | 10,708 European ancestry individuals | T | 0.85 | 2E-1534 | 1533.699 | rs429358 | 1.251 | protein measurement (EFO:0004747) |
PMID:34648354 |
GWAS865589_H | GCST90267627 | Alzheimer's disease, proxy Alzheimer's disease or related dementias | 6,796 African American cases, 4,385 African American maternal cases, 2,256 African American paternal cases, 69,627 African American controls | T | NR | 6E-150 | 149.222 | rs429358 | N/A | family history of Alzheimer’s disease (EFO:0009268) |
PMID:36543923 |
None Available | GCST90271622 | Nonalcoholic fatty liver disease | 691,479 European ancestry, African American or Afro-Caribbean, East Asian ancestry, Hispanic or Latin American, South Asian ancestry individuals | T | 0.85 | 4E-34 | 33.398 | rs429358 | 12.18 | non-alcoholic fatty liver disease (EFO:0003095) |
PMID:37709864 |
GWAS889166_H | GCST90269633 | Triglycerides in large LDL (UKB data field 23536) | 88,329 European ancestry individuals | C | 0.155555 | 2E-50 | 49.699 | rs429358 | 0.0960259 | triglycerides in large LDL measurement (EFO:0022319) |
PMID:36764567 |
None Available | GCST90269666 | Cholesteryl esters in medium HDL (UKB data field 23569) | 88,329 European ancestry individuals | C | 0.155555 | 4E-43 | 42.398 | rs429358 | 0.0835073 | cholesteryl ester measurement (EFO:0010351) |
PMID:36764567 |
GWAS894114_H | GCST90269681 | Phospholipids to total lipids in very large VLDL percentage (UKB data field 23584) | 87,620 European ancestry individuals | C | 0.155872 | 7E-66 | 65.155 | rs429358 | 0.111748 | phospholipids:total lipids ratio (EFO:0020946) |
PMID:36764567 |
GWAS897296_H | GCST90269689 | Free cholesterol to total lipids in large VLDL percentage (UKB data field 23592) | 88,321 European ancestry individuals | C | 0.155563 | 1E-59 | 59 | rs429358 | 0.105862 | free cholesterol to total lipids in large VLDL percentage (EFO:0022281) |
PMID:36764567 |
GWAS899297_H | GCST90269640 | Triglycerides in medium LDL (UKB data field 23543) | 88,329 European ancestry individuals | C | 0.155555 | 5E-57 | 56.302 | rs429358 | 0.10196 | triglycerides in medium LDL measurement (EFO:0022322) |
PMID:36764567 |
GWAS901503_H | GCST90432152 | Abdominal aortic aneurysm | 37,214 European ancestry cases, 997,776 European ancestry controls, 2,007 African ancestry cases, 88,331 African ancestry controls | ? | NR | 5E-39 | 38.302 | rs429358 | 0.1439 | Abdominal Aortic Aneurysm (EFO:0004214) |
PMID:37845353 |
GWAS902498_H | GCST90269665 | Cholesterol in medium HDL (UKB data field 23568) | 88,329 European ancestry individuals | C | 0.155555 | 9E-39 | 38.046 | rs429358 | 0.0787552 | cholesterol in medium HDL measurement (EFO:0021903) |
PMID:36764567 |
GWAS908893_H | GCST90269690 | Triglycerides to total lipids in large VLDL percentage (UKB data field 23593) | 88,321 European ancestry individuals | C | 0.155563 | 2E-33 | 32.699 | rs429358 | 0.0784912 | triglycerides to total lipids in large VLDL percentage (EFO:0022332) |
PMID:36764567 |
None Available | GCST90269711 | Phospholipids to total lipids in large LDL percentage (UKB data field 23614) | 88,329 European ancestry individuals | C | 0.155555 | 2E-42 | 41.699 | rs429358 | 0.0888502 | phospholipids:total lipids ratio (EFO:0020946) |
PMID:36764567 |
GWAS914097_H | GCST011496 | Abdominal aortic aneurysm | 7,642 European ancestry cases, 172,172 European ancestry controls | C | 0.1401 | 1E-15 | 15 | rs429358 | 1.17 | Abdominal Aortic Aneurysm (EFO:0004214) |
PMID:32981348 |
GWAS915792_H | GCST007600 | Alzheimer's disease | 952 European ancestry male cases, 1,789 European ancestry female cases, 6,337 European ancestry male controls, 8,402 European ancestry female controls | ? | NR | 1E-53 | 53 | rs429358 | 3.921738 | PMID:30636644 | |
GWAS916932_H | GCST007600 | Alzheimer's disease | 952 European ancestry male cases, 1,789 European ancestry female cases, 6,337 European ancestry male controls, 8,402 European ancestry female controls | ? | NR | 2E-91 | 90.699 | rs429358 | 3.9972339 | PMID:30636644 | |
None Available | GCST007600 | Alzheimer's disease | 952 European ancestry male cases, 1,789 European ancestry female cases, 6,337 European ancestry male controls, 8,402 European ancestry female controls | ? | NR | 3E-31 | 30.523 | rs429358 | 3.8628085 | PMID:30636644 | |
None Available | GCST007780 | Parkinson's disease (age of onset) | 17,996 cases | ? | NR | 6E-8 | 7.222 | rs429358 | 0.707 | age at onset (EFO:0004847) |
PMID:30957308 |
GWAS921858_H | GCST009890 | Parental lifespan | at least 500,193 European ancestry offspring | T | 0.85 | 3E-83 | 82.523 | rs429358 | 1.0561 | parental longevity (EFO:0007796) |
PMID:30642433 |
GWAS924565_H | GCST011950 | White matter hyperintensity volume (adjusted for hypertension) | 46,055 European ancestry individuals | C | 0.8556 | 0.000003 | 5.523 | rs429358 | 0.0401 | white matter hyperintensity measurement (EFO:0005665) |
PMID:33293549 |
GWAS925454_H | GCST011949 | White matter hyperintensity volume (adjusted for hypertension) | 46,055 European ancestry individuals, 2,469 African American individuals | C | 0.8556 | 0.000005 | 5.302 | rs429358 | 0.0399 | white matter hyperintensity measurement (EFO:0005665) |
PMID:33293549 |
None Available | GCST011947 | White matter hyperintensity volume | 48,454 European ancestry individuals | C | 0.8556 | 1E-7 | 7 | rs429358 | 0.0447 | white matter hyperintensity measurement (EFO:0005665) |
PMID:33293549 |
None Available | GCST009859 | Adult onset asthma or type 2 diabetes | 33,418 European ancestry asthma cases, 393,186 European ancestry asthma controls, 159,208 European ancestry diabetes cases and controls | ? | NR | 2E-10 | 9.699 | rs429358 | N/A | adult onset asthma (EFO:1002011) |
PMID:31669095 |
None Available | GCST011037 | Parkinson's disease progression (cognitive) | 2,788 individuals | C | 0.14 | 3E-13 | 12.523 | rs429358 | 0.38 | disease progression measurement (EFO:0008336) |
PMID:33111402 |
None Available | GCST011039 | Parkinson's disease progression (composite) | 2,755 individuals | C | 0.14 | 1E-8 | 8 | rs429358 | 0.35 | disease progression measurement (EFO:0008336) |
PMID:33111402 |
None Available | GCST011946 | White matter hyperintensity volume | 2,516 African American individuals, 48,454 European ancestry individuals | C | 0.8556 | 2E-7 | 6.699 | rs429358 | 0.0445 | white matter hyperintensity measurement (EFO:0005665) |
PMID:33293549 |
GWAS942385_H | GCST006611 | HDL cholesterol | 215,551 European ancestry individuals, 57,332 African American individuals, 24,743 Hispanic individuals | T | 0.8416 | 1E-142 | 142 | rs429358 | 0.093 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:30275531 |
None Available | GCST006136 | Alzheimer's disease progression score | 944 European ancestry individuals | ? | NR | 4E-33 | 32.398 | rs429358 | N/A | Alzheimer's disease biomarker measurement (EFO:0006514) |
PMID:29860282 |
None Available | GCST006134 | Hippocampal volume | 926 European ancestry individuals | ? | NR | 1E-10 | 10 | rs429358 | N/A | hippocampal volume (EFO:0005035) |
PMID:29860282 |
None Available | GCST006135 | Cortical amyloid beta load | 936 European ancestry individuals | ? | NR | 3E-50 | 49.523 | rs429358 | N/A | cerebral amyloid deposition measurement (EFO:0007707) |
PMID:29860282 |
GWAS959065_H | GCST007615 | C-reactive protein levels | 148,164 European ancestry individuals | T | 0.85 | 4E-328 | 327.398 | rs429358 | 0.247 | C-reactive protein measurement (EFO:0004458) |
PMID:30388399 |
GWAS959225_H | GCST006904 | Cerebral amyloid deposition (PET imaging) | 983 European ancestry individuals | C | 0.21 | 9E-30 | 29.046 | rs429358 | 0.18 | cerebral amyloid deposition measurement (EFO:0007707) |
PMID:30361487 |
GWAS962202_H | GCST007615 | C-reactive protein levels | 148,164 European ancestry individuals | T | 0.85 | 6E-363 | 362.222 | rs429358 | 0.24 | C-reactive protein measurement (EFO:0004458) |
PMID:30388399 |
None Available | GCST90428448 | Estimated glomerular filtration rate (cystatin c) | 406,504 European ancestry individuals | C | NR | 8E-37 | 36.097 | rs429358 | 0.035446 | glomerular filtration rate (EFO:0005208) |
PMID:39256582 |
None Available | GCST90428447 | Estimated glomerular filtration rate (creatinine) | 406,504 European ancestry individuals | C | NR | 8E-41 | 40.097 | rs429358 | 0.0383775 | glomerular filtration rate (EFO:0005208) |
PMID:39256582 |
None Available | GCST90002396 | Mean reticulocyte volume | 408,112 British individuals | C | 0.154459 | 4E-21 | 20.398 | rs429358 | 0.029556824 | mean reticulocyte volume (EFO:0010701) |
PMID:32888494 |
None Available | GCST010417 | Liver fat content (MRI proton density fat fraction measure) | 14,440 European ancestry individuals | T | 0.848199 | 6E-11 | 10.222 | rs429358 | 0.073 | liver fat measurement (EFO:0010821) liver disease biomarker (EFO:0006845) |
PMID:32247823 |
None Available | GCST90428446 | Estimated glomerular filtration rate (creatinine, cystatin c) | 406,504 European ancestry individuals | C | NR | 4E-51 | 50.398 | rs429358 | 0.042415 | glomerular filtration rate (EFO:0005208) |
PMID:39256582 |
None Available | GCST010988 | Adult body size | 453,169 European ancestry individuals | T | 0.845733 | 3E-17 | 16.523 | rs429358 | 0.0160691 | body height (EFO:0004339) |
PMID:32376654 |
GWAS977964_H | GCST011348 | High density lipoprotein cholesterol levels | 76,081 European ancestry individuals, 127,395 Japanese ancestry individuals | ? | NR | 2E-58 | 57.699 | rs429358 | 0.1026 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:33339817 |
None Available | GCST007881 | Dementia with Lewy bodies | 720 European ancestry cases, 6,490 European ancestry controls | ? | NR | 6E-17 | 16.222 | rs429358 | 2.28 | Lewy body dementia (EFO:0006792) |
PMID:31065058 |
None Available | GCST90444489 | Metabolic syndrome | 10,684 Korean ancestry cases, 51,630 Korean ancestry controls | ? | NR | 1E-14 | 14 | rs429358 | 0.190901 | metabolic syndrome (EFO:0000195) |
PMID:39349817 |
None Available | GCST012140 | High-sensitivity C-reactive protein levels in HIV infection | 4,675 European ancestry individuals, 1,732 African ancestry individuals, 645 Admixed American individuals | C | 0.154 | 2E-22 | 21.699 | rs429358 | 0.282 | C-reactive protein measurement (EFO:0004458) |
PMID:33095540 |
GWAS982699_H | GCST011350 | C-reactive protein levels | 76,081 European ancestry individuals, 127,395 Japanese ancestry individuals | ? | NR | 2E-140 | 139.699 | rs429358 | 0.1672 | C-reactive protein measurement (EFO:0004458) |
PMID:33339817 |
GWAS984900_H | GCST90104006 | Familial combined hyperlipidemia defined by Consensus criteria | 39,961 British ancestry cases, 309,261 British ancestry controls | T | 0.844393 | 3E-226 | 225.523 | rs429358 | 0.321864 | PMID:34906840 | |
None Available | GCST90432154 | Basal ganglia structure | 34,794 British ancestry individuals | C | NR | 8E-11 | 10.097 | rs429358 | N/A | brain measurement (EFO:0004464) |
PMID:39353893 |
GWAS986809_H | GCST90242425 | Protein CEI levels (C5orf38.6378.2.3) | 3,301 European ancestry individuals | C | 0.153 | 4E-159 | 158.398 | rs429358 | 0.82 | protein CEI measurement (EFO:0801936) |
PMID:29875488 |
GWAS987959_H | GCST90240197 | Adhesion G-protein coupled receptor F1 levels (ADGRF1.11243.90.3) | 3,301 European ancestry individuals | C | 0.153 | 7E-30 | 29.155 | rs429358 | 0.38 | adhesion G-protein coupled receptor F1 measurement (EFO:0801347) |
PMID:29875488 |
None Available | GCST90240210 | ADP-ribosylation factor-like protein 1 levels (ARL1.12392.30.3) | 3,301 European ancestry individuals | C | 0.153 | 1E-19 | 19 | rs429358 | 0.3 | ADP-ribosylation factor-like protein 1 measurement (EFO:0801354) |
PMID:29875488 |
GWAS989753_H | GCST90242240 | PH and SEC7 domain-containing protein 1 levels (PSD.13055.53.3) | 3,301 European ancestry individuals | C | 0.153 | 2E-96 | 95.699 | rs429358 | 0.66 | PH and SEC7 domain-containing protein 1 measurement (EFO:0803302) |
PMID:29875488 |
None Available | GCST90240441 | Beta-soluble NSF attachment protein levels (NAPB.12655.30.3) | 3,301 European ancestry individuals | C | 0.153 | 1E-25 | 25 | rs429358 | 0.35 | beta-soluble NSF attachment protein measurement (EFO:0801423) |
PMID:29875488 |
None Available | GCST90451696 | Alzheimer's disease | 345 Puerto Rican cases, 303 Puerto Rican controls | C | 0.13 | 1E-7 | 7 | rs429358 | 2.19 | PMID:39295643 | |
None Available | GCST90448696 | Breakthrough COVID-19 severity after at least one dose of a COVID-19 vaccine | 3,860 European ancestry cases, 70,802 European ancestry controls | C | 0.15 | 1E-8 | 8 | rs429358 | 1.21 | response to COVID-19 vaccine (EFO:0803362) |
PMID:39384777 |
None Available | GCST90451698 | Type 2 diabetes mellitus or coronary artery disease (pleiotropy) | 74,124 European ancestry type 2 diabetes cases, 181,522 European ancestry coronary artery disease cases, 1,808,174 European ancestry controls | ? | NR | 6E-65 | 64.222 | rs429358 | N/A | coronary artery disease (EFO:0001645) |
PMID:38062574 |
None Available | GCST90242148 | Nuclear receptor-binding protein levels (NRBP1.12616.45.3) | 3,301 European ancestry individuals | C | 0.153 | 1E-24 | 24 | rs429358 | 0.34 | nuclear receptor-binding protein measurement (EFO:0801854) |
PMID:29875488 |
None Available | GCST90242208 | PDZK1-interacting protein 1 levels (PDZK1IP1.8260.13.3) | 3,301 European ancestry individuals | C | 0.153 | 3E-26 | 25.523 | rs429358 | 0.35 | PDZK1-interacting protein 1 measurement (EFO:0801869) |
PMID:29875488 |
None Available | GCST90129602 | Chronic elevation of alanine aminotransferase (cALT) levels | 95,472 European ancestry cases, 68,725 European ancestry controls | C | 0.139 | 5E-19 | 18.302 | rs429358 | 0.094 | serum alanine aminotransferase measurement (EFO:0004735) |
PMID:35654975 |
None Available | GCST90240886 | Deoxycytidine kinase levels (DCK.9836.20.3) | 3,301 European ancestry individuals | C | 0.153 | 7E-21 | 20.155 | rs429358 | 0.31 | deoxycytidine kinase measurement (EFO:0801523) |
PMID:29875488 |
None Available | GCST90131354 | Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net25_Node5) | 34,691 British ancestry individuals | ? | NR | 6E-12 | 11.222 | rs429358 | 0.072033 | functional brain measurement (EFO:0007849) |
PMID:35393594 |
GWAS996050_H | GCST90240603 | Cardiotrophin-1 levels (CTF1.13732.79.3) | 3,301 European ancestry individuals | C | 0.153 | 4E-148 | 147.398 | rs429358 | 0.8 | cardiotrophin-1 measurement (EFO:0020235) |
PMID:29875488 |
None Available | GCST90131412 | Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node42) | 34,691 British ancestry individuals | ? | NR | 4E-13 | 12.398 | rs429358 | 0.0721823 | functional brain measurement (EFO:0007849) |
PMID:35393594 |
GWAS997536_H | GCST90103982 | Low high density lipoprotein cholesterol levels | 20,763 Taiwanese ancestry males | ? | NR | 8E-13 | 12.097 | rs429358 | N/A | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:35238325 |
None Available | GCST90092914 | Triglyceride levels in medium LDL | 115,082 European ancestry individuals | T | 0.845176 | 1E-64 | 64 | rs429358 | 0.0946684 | triglyceride measurement (EFO:0004530) low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:35213538 |
GWAS999626_H | GCST90092892 | Cholesterol levels in medium HDL | 115,082 European ancestry individuals | T | 0.845176 | 2E-45 | 44.699 | rs429358 | 0.0744857 | total cholesterol measurement (EFO:0004574) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:35213538 |
GWAS999689_H | GCST90025404 | Lysophosphatidylcholine (20:1) [sn1] levels | 4,492 European ancestry individuals | C | NR | 9E-9 | 8.046 | rs429358 | 0.182 | lysophosphatidylcholine 20:1 measurement (EFO:0021457) |
PMID:35668104 |
None Available | GCST90025200 | Total Lysophosphatidylethanolamine levels | 6,057 European ancestry individuals | C | NR | 2E-14 | 13.699 | rs429358 | N/A | phosphatidylethanolamine measurement (EFO:0010228) |
PMID:35668104 |
GWAS999742_H | GCST90308740 | Cognitive domain scores for executive function | 43,500 European ancestry individuals | ? | NR | 7E-20 | 19.155 | rs429358 | N/A | executive function measurement (EFO:0009332) |
PMID:37349795 |
GWAS999745_H | GCST90308734 | Cognitive domain scores for memory | 43,500 European ancestry individuals | ? | NR | 4E-51 | 50.398 | rs429358 | N/A | memory performance (EFO:0004874) |
PMID:37349795 |
GWAS999746_H | GCST90308736 | Cognitive domain scores for language | 60,296 European ancestry individuals | ? | NR | 4E-206 | 205.398 | rs429358 | N/A | language measurement (EFO:0007797) |
PMID:37349795 |
GWAS999747_H | GCST90308735 | Cognitive domain scores for language | 103,796 European ancestry individuals | ? | NR | 3E-158 | 157.523 | rs429358 | N/A | language measurement (EFO:0007797) |
PMID:37349795 |
None Available | GCST90092811 | 3-Hydroxybutyrate levels | 113,594 European ancestry individuals | T | 0.845115 | 2E-23 | 22.699 | rs429358 | 0.0564519 | 3-hydroxybutyrate measurement (EFO:0010982) |
PMID:35213538 |
None Available | GCST90020025 | Waist-to-hip ratio adjusted for BMI | 219,872 British ancestry women | C | NR | 2E-11 | 10.699 | rs429358 | 0.0262381 | BMI-adjusted waist-hip ratio (EFO:0007788) |
PMID:34021172 |
None Available | GCST90241094 | Epididymal-specific lipocalin-10 levels (LCN10.13007.66.3) | 3,301 European ancestry individuals | C | 0.153 | 1E-20 | 20 | rs429358 | 0.31 | epididymal-specific lipocalin-10 measurement (EFO:0801576) |
PMID:29875488 |
GWAS999948_H | GCST90243133 | Tubulin-specific chaperone A levels (TBCA.12501.10.3) | 3,301 European ancestry individuals | C | 0.153 | 5E-646 | 645.302 | rs429358 | 1.34 | tubulin-specific chaperone A measurement (EFO:0802166) |
PMID:29875488 |
GWAS1000182_H | GCST90018730 | C-reactive protein | 83,025 East Asian ancestry individuals | C | 0.10215 | 2E-53 | 52.699 | rs429358 | 0.120771 | C-reactive protein measurement (EFO:0004458) |
PMID:34594039 |
GWAS1000190_H | GCST90018736 | HDL cholesterol | 74,970 East Asian ancestry individuals | C | 0.102979 | 3E-30 | 29.523 | rs429358 | 0.0899756 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:34594039 |
GWAS1000196_H | GCST90131906 | Whole brain free water diffusion (multivariate analysis) | 23,543 European ancestry individuals | ? | NR | 8E-15 | 14.097 | rs429358 | N/A | brain measurement (EFO:0004464) |
PMID:35505052 |
GWAS1000198_H | GCST90093287 | Alzheimer's disease (age of onset) | 10,216 European ancestry individuals | ? | NR | 4E-497 | 496.398 | rs429358 | 3.32 | age at onset (EFO:0004847) |
PMID:33637690 |
GWAS1000205_H | GCST90241096 | Epididymis-specific alpha-mannosidase levels (MAN2B2.9251.28.3) | 3,301 European ancestry individuals | C | 0.153 | 8E-12 | 11.097 | rs429358 | 0.23 | epididymis-specific alpha-mannosidase measurement (EFO:0801577) |
PMID:29875488 |
GWAS1000207_H | GCST90241113 | Estrogen sulfotransferase levels (SULT1E1.9878.3.3) | 3,301 European ancestry individuals | C | 0.153 | 3E-34 | 33.523 | rs429358 | 0.4 | estrogen sulfotransferase measurement (EFO:0801586) |
PMID:29875488 |
None Available | GCST90241699 | Killer cell immunoglobulin-like receptor 2DL5A levels (KIR2DL5A.8000.17.3) | 3,301 European ancestry individuals | C | 0.153 | 8E-26 | 25.097 | rs429358 | 0.35 | killer cell immunoglobulin-like receptor 2DL5A measurement (EFO:0801745) |
PMID:29875488 |
None Available | GCST90131904 | Whole brain restricted isotropic diffusion (multivariate analysis) | 23,543 European ancestry individuals | ? | NR | 4E-15 | 14.398 | rs429358 | N/A | brain measurement (EFO:0004464) |
PMID:35505052 |
GWAS1000830_H | GCST90092866 | Triglyceride levels in large LDL | 115,082 European ancestry individuals | T | 0.845176 | 3E-58 | 57.523 | rs429358 | 0.09009 | triglyceride measurement (EFO:0004530) low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:35213538 |
None Available | GCST90025292 | Ceramide (d18:2/20:0) levels | 4,492 European ancestry individuals | C | NR | 9E-9 | 8.046 | rs429358 | 0.182 | ceramide measurement (EFO:0010222) |
PMID:35668104 |
GWAS1001183_H | GCST90092873 | Free cholesterol to total lipids ratio in large VLDL | 115,071 European ancestry individuals | T | 0.84517 | 3E-76 | 75.523 | rs429358 | 0.104559 | very low density lipoprotein cholesterol measurement (EFO:0008317) free cholesterol:total lipids ratio (EFO:0020945) |
PMID:35213538 |
None Available | GCST90242741 | Selenoprotein S levels (VIMP.11286.78.3) | 3,301 European ancestry individuals | C | 0.153 | 6E-35 | 34.222 | rs429358 | 0.41 | selenoprotein S measurement (EFO:0802046) |
PMID:29875488 |
None Available | GCST90093025 | Phospholipids to total lipids ratio in very large VLDL | 114,160 European ancestry individuals | T | 0.844871 | 1E-76 | 76 | rs429358 | 0.105943 | very low density lipoprotein cholesterol measurement (EFO:0008317) phospholipids:total lipids ratio (EFO:0020946) |
PMID:35213538 |
None Available | GCST90131409 | Brain rsFMRI measurement (amplitude of low frequency fluctations) (Net100_Node39) | 34,691 British ancestry individuals | ? | NR | 2E-15 | 14.699 | rs429358 | 0.0794547 | functional brain measurement (EFO:0007849) |
PMID:35393594 |
GWAS1002494_H | GCST90276157 | Alzheimer's disease and Lewy body co-pathology | 1,072 European ancestry postmortem cases, 1,263 European ancestry postmortem controls | C | 0.271 | 1E-52 | 52 | rs429358 | 4.24 | Lewy body dementia (EFO:0006792) |
PMID:37700353 |
GWAS1002495_H | GCST90276158 | Alzheimer's disease pathology | 2,492 European ancestry postmortem cases, 1,263 European ancestry postmortem controls | C | 0.271 | 1E-69 | 69 | rs429358 | 4.22 | PMID:37700353 | |
GWAS1002560_H | GCST90092890 | Triglyceride levels in LDL | 115,082 European ancestry individuals | T | 0.845176 | 1E-57 | 57 | rs429358 | 0.0894871 | triglyceride measurement (EFO:0004530) low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:35213538 |
None Available | GCST90092894 | Cholesteryl ester levels in medium HDL | 115,082 European ancestry individuals | T | 0.845176 | 2E-50 | 49.699 | rs429358 | 0.0789013 | cholesteryl ester measurement (EFO:0010351) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:35213538 |
None Available | GCST90242903 | Stromal interaction molecule 1 levels (STIM1.9271.101.3) | 3,301 European ancestry individuals | C | 0.153 | 1E-14 | 14 | rs429358 | 0.26 | stromal interaction molecule 1 measurement (EFO:0802093) |
PMID:29875488 |
GWAS1003042_H | GCST90241762 | Leucine-rich repeat neuronal protein 1 levels (LRRN1.11293.14.3) | 3,301 European ancestry individuals | C | 0.153 | 3E-418 | 417.523 | rs429358 | 1.18 | leucine-rich repeat neuronal protein 1 measurement (EFO:0801760) |
PMID:29875488 |
GWAS1003064_H | GCST90024164 | Lysophosphatidylcholine (20:0) [sn2] levels | 4,492 European ancestry individuals | C | NR | 0.000008 | 5.097 | rs429358 | 0.14 | lysophosphatidylcholine 20:0 measurement (EFO:0021456) |
PMID:35668104 |
GWAS1003065_H | GCST90024165 | Lysophosphatidylcholine (20:1) [sn1] levels | 4,492 European ancestry individuals | C | NR | 0.000006 | 5.222 | rs429358 | 0.143 | lysophosphatidylcholine 20:1 measurement (EFO:0021457) |
PMID:35668104 |
GWAS1003097_H | GCST90092865 | Phospholipids to total lipids ratio in large LDL | 115,082 European ancestry individuals | T | 0.845176 | 5E-54 | 53.302 | rs429358 | 0.0883229 | low density lipoprotein cholesterol measurement (EFO:0004611) phospholipids:total lipids ratio (EFO:0020946) |
PMID:35213538 |
GWAS1003295_H | GCST90104611 | Amyloid beta positivity in normal cognition | 175 Korean ancestry individuals | T | NR | 7E-8 | 7.155 | rs429358 | 0.8055 | amyloid-beta measurement (EFO:0005194) |
PMID:35366586 |
GWAS1003296_H | GCST90104612 | Amyloid beta positivity in normal cognition | 196 European ancestry individuals | ? | NR | 4E-7 | 6.398 | rs429358 | N/A | amyloid-beta measurement (EFO:0005194) |
PMID:35366586 |
GWAS1003318_H | GCST90024526 | Sulfatide (d18:1/24:0(OH) levels) levels | 4,492 European ancestry individuals | C | NR | 9E-7 | 6.046 | rs429358 | 0.151 | ceramide measurement (EFO:0010222) |
PMID:35668104 |
None Available | GCST90100220 | Estimated glomerular filtration rate (creatinine) | 1,205,871 European ancestry individuals, 168,300 East Asian ancestry individuals, 63,553 African ancestry individuals, 23,509 Hispanic or Latin American individuals, 22,103 African American individuals, 21,791 Central Asian or South Asian ancestry individuals, 1,502 Middle Eastern ancestry individuals, 939 other admixed ancestry individuals, 602 Native American ancestry individuals, 150 Asian ancestry individuals, 339 individuals | C | 0.152 | 2E-18 | 17.699 | rs429358 | 8.776 | glomerular filtration rate (EFO:0005208) |
PMID:35710981 |
GWAS1003331_H | GCST90018950 | C-reactive protein | 353,466 European ancestry individuals, 83,025 East Asian ancestry individuals | C | NR | 1E-1420 | 1420 | rs429358 | 0.2447 | C-reactive protein measurement (EFO:0004458) |
PMID:34594039 |
None Available | GCST90131905 | Whole brain restricted directional diffusion (multivariate analysis) | 23,543 European ancestry individuals | ? | NR | 9E-13 | 12.046 | rs429358 | N/A | brain measurement (EFO:0004464) |
PMID:35505052 |
GWAS1003646_H | GCST90092879 | Triglycerides to total lipids ratio in large VLDL | 115,071 European ancestry individuals | T | 0.84517 | 1E-43 | 43 | rs429358 | 0.07883 | triglycerides:total lipids ratio (EFO:0020947) very low density lipoprotein cholesterol measurement (EFO:0008317) |
PMID:35213538 |
GWAS1003936_H | GCST90308732 | Cognitive domain scores for memory | 103,796 European ancestry individuals | ? | NR | 8E-321 | 320.097 | rs429358 | N/A | memory performance (EFO:0004874) |
PMID:37349795 |
GWAS1003937_H | GCST90308733 | Cognitive domain scores for memory | 60,296 European ancestry individuals | ? | NR | 3E-374 | 373.523 | rs429358 | N/A | memory performance (EFO:0004874) |
PMID:37349795 |
GWAS1003938_H | GCST90308737 | Cognitive domain scores for language | 43,500 European ancestry individuals | ? | NR | 3E-16 | 15.523 | rs429358 | N/A | language measurement (EFO:0007797) |
PMID:37349795 |
GWAS1003939_H | GCST90308738 | Cognitive domain scores for executive function | 103,796 European ancestry individuals | ? | NR | 9E-145 | 144.046 | rs429358 | N/A | executive function measurement (EFO:0009332) |
PMID:37349795 |
GWAS1003940_H | GCST90308739 | Cognitive domain scores for executive function | 60,296 European ancestry individuals | ? | NR | 2E-170 | 169.699 | rs429358 | N/A | executive function measurement (EFO:0009332) |
PMID:37349795 |
GWAS1004171_H | GCST90233559 | ADP-ribosylation factor-like protein 2 level in Chronic kidney disease with hypertension and no diabetes (12587_65) | 466 African American individuals | C | 0.21 | 8E-21 | 20.097 | rs429358 | 0.7 | PMID:35870639 | |
None Available | GCST90267930 | Right hippocampal volume | 65,791 European ancestry, East Asian ancestry individuals | C | 0.092637 | 6E-9 | 8.222 | rs429358 | 0.0461954 | hippocampal volume (EFO:0005035) |
PMID:37337106 |
None Available | GCST90297541 | Plasma amyloid beta 42 to 40 ratio | 1,991 European ancestry individuals | ? | NR | 6E-18 | 17.222 | rs429358 | 0.363 | amyloid-beta measurement (EFO:0005194) |
PMID:37208024 |
None Available | GCST90297542 | Plasma neurofilament light levels | 2,380 European ancestry individuals | ? | NR | 8E-10 | 9.097 | rs429358 | 0.184 | neurofilament light chain measurement (EFO:0009178) |
PMID:37208024 |
GWAS1004438_H | GCST90238739 | Hemoglobin subunit theta-1 level in Chronic kidney disease with hypertension and no diabetes (7965_25) | 466 African American individuals | C | 0.21 | 9E-56 | 55.046 | rs429358 | 1.04 | PMID:35870639 | |
GWAS1004500_H | GCST90302077 | Saturated fatty acids | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8431 | 5E-87 | 86.302 | rs429358 | 0.1096 | saturated fatty acids measurement (EFO:0022304) |
PMID:38448586 |
None Available | GCST90244370 | Sterol ester (27:1/14:0) levels | 4,642 European ancestry women | C | NR | 1E-9 | 9 | rs429358 | 0.1696 | PMID:36193934 | |
None Available | GCST90244376 | Sterol ester (27:1/18:0) levels | 4,642 European ancestry women | C | NR | 2E-8 | 7.699 | rs429358 | 0.1578 | PMID:36193934 | |
None Available | GCST90267908 | Left hippocampal volume | 65,791 European ancestry, East Asian ancestry individuals | C | 0.092637 | 1E-10 | 10 | rs429358 | 0.0507656 | hippocampal volume (EFO:0005035) |
PMID:37337106 |
None Available | GCST90270902 | Cognitive performance (memory) (longitudinal) | 3,042 European ancestry individuals aged 65 years or older | C | 0.1073 | 6E-9 | 8.222 | rs429358 | 0.2252 | memory performance (EFO:0004874) |
PMID:37089073 |
None Available | GCST90270905 | Cognitive performance (global cognitive function) (longitudinal) | 3,013 European ancestry individuals aged 65 years or older | C | 0.1074 | 2E-8 | 7.699 | rs429358 | 0.2189 | cognitive function measurement (EFO:0008354) |
PMID:37089073 |
GWAS1004547_H | GCST90301985 | Triglycerides in IDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.843 | 1E-100 | 100 | rs429358 | 0.1169 | triglycerides in IDL measurement (EFO:0022149) |
PMID:38448586 |
GWAS1004779_H | GCST90302078 | Ratio of saturated fatty acids to total fatty acids | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.843 | 8E-30 | 29.097 | rs429358 | 0.0636 | fatty acid measurement (EFO:0005110) |
PMID:38448586 |
None Available | GCST90302003 | Phospholipids in large HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8432 | 3E-64 | 63.523 | rs429358 | 0.0945 | phospholipids in large HDL measurement (EFO:0022190) |
PMID:38448586 |
GWAS1005042_H | GCST90302123 | Total cholesterol levels in VLDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.843 | 7E-138 | 137.155 | rs429358 | 0.1367 | total cholesterol measurement (EFO:0004574) very low density lipoprotein cholesterol measurement (EFO:0008317) |
PMID:38448586 |
GWAS1005078_H | GCST90302053 | Triglycerides in medium LDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8431 | 3E-124 | 123.523 | rs429358 | 0.1305 | triglycerides in medium LDL measurement (EFO:0022322) |
PMID:38448586 |
None Available | GCST90103484 | ICD10 M54: Dorsalgia | 119,110 European ancestry cases, 909,847 European ancestry controls | C | 0.17 | 2E-11 | 10.699 | rs429358 | 0.96 | Back pain (HP:0003418) |
PMID:35110524 |
GWAS1005114_H | GCST90302017 | Triglycerides in large LDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8431 | 1E-115 | 115 | rs429358 | 0.1256 | triglycerides in large LDL measurement (EFO:0022319) |
PMID:38448586 |
GWAS1005164_H | GCST90302002 | Concentration of large HDL particles | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8432 | 2E-68 | 67.699 | rs429358 | 0.0976 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:38448586 |
None Available | GCST90301999 | Free cholesterol in large HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8432 | 2E-57 | 56.699 | rs429358 | 0.0892 | free cholesterol in large HDL measurement (EFO:0022157) |
PMID:38448586 |
None Available | GCST90302001 | Total lipids in large HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8432 | 2E-68 | 67.699 | rs429358 | 0.0975 | total lipids in large HDL (EFO:0022189) |
PMID:38448586 |
GWAS1005169_H | GCST90302034 | Cholesteryl esters to total lipids ratio in medium HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8434 | 1E-54 | 54 | rs429358 | 0.0866 | cholesteryl esters:total lipids ratio (EFO:0020944) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:38448586 |
None Available | GCST90233177 | Leucine-rich repeat neuronal protein 1 level in Chronic kidney disease with hypertension and no diabetes (11293_14) | 466 African American individuals | C | 0.21 | 1E-68 | 68 | rs429358 | 1.11 | protein measurement (EFO:0004747) |
PMID:35870639 |
None Available | GCST90302122 | Valine levels | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8431 | 9E-10 | 9.046 | rs429358 | 0.0349 | valine measurement (EFO:0009792) |
PMID:38448586 |
GWAS1005309_H | GCST90302104 | Total cholesterol in small VLDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.843 | 2E-148 | 147.699 | rs429358 | 0.1412 | total cholesterol in small VLDL (EFO:0022171) |
PMID:38448586 |
GWAS1005355_H | GCST90302059 | Cholesterol esters in medium VLDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8431 | 1E-105 | 105 | rs429358 | 0.1203 | cholesterol esters in medium VLDL measurement (EFO:0022182) |
PMID:38448586 |
GWAS1005424_H | GCST90302035 | Free cholesterol in medium HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8432 | 9E-54 | 53.046 | rs429358 | 0.087 | free cholesterol in medium HDL measurement (EFO:0022267) |
PMID:38448586 |
GWAS1005427_H | GCST90302040 | Phospholipids to total lipids ratio in medium HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8431 | 3E-52 | 51.523 | rs429358 | 0.0832 | phospholipids:total lipids ratio (EFO:0020946) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:38448586 |
GWAS1005429_H | GCST90302037 | Total lipids in medium HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8433 | 9E-72 | 71.046 | rs429358 | 0.1013 | total lipids in medium HDL measurement (EFO:0022310) |
PMID:38448586 |
GWAS1005599_H | GCST90302127 | Total cholesterol to total lipids ratio in very large HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8433 | 1E-97 | 97 | rs429358 | 0.1169 | cholesterol:total lipids ratio (EFO:0020943) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:38448586 |
GWAS1005606_H | GCST90302111 | Concentration of small VLDL particles | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.843 | 9E-87 | 86.046 | rs429358 | 0.1083 | very low density lipoprotein cholesterol measurement (EFO:0008317) |
PMID:38448586 |
GWAS1005609_H | GCST90302110 | Total lipids in small VLDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.843 | 4E-96 | 95.398 | rs429358 | 0.1139 | total lipids in small VLDL (EFO:0022148) |
PMID:38448586 |
None Available | GCST90235743 | Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase level in Chronic kidney disease with hypertension and no diabetes (21508_7) | 466 African American individuals | C | 0.21 | 6E-43 | 42.222 | rs429358 | 0.95 | PMID:35870639 | |
GWAS1005813_H | GCST90236150 | Kinetochore protein Spc25 level in Chronic kidney disease with hypertension and no diabetes (22782_80) | 466 African American individuals | C | 0.21 | 4E-112 | 111.398 | rs429358 | 1.27 | PMID:35870639 | |
GWAS1005880_H | GCST90302129 | Cholesteryl esters to total lipids ratio in very large HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8431 | 4E-82 | 81.398 | rs429358 | 0.1068 | cholesteryl esters:total lipids ratio (EFO:0020944) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:38448586 |
GWAS1006007_H | GCST90302039 | Phospholipids in medium HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8431 | 3E-63 | 62.523 | rs429358 | 0.0949 | phospholipids in medium HDL measurement (EFO:0022295) |
PMID:38448586 |
GWAS1006008_H | GCST90302038 | Concentration of medium HDL particles | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8432 | 2E-69 | 68.699 | rs429358 | 0.0993 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:38448586 |
GWAS1006131_H | GCST90301972 | Mean diameter of HDL particles | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8432 | 7E-31 | 30.155 | rs429358 | 0.0645 | high density lipoprotein particle size measurement (EFO:0008592) |
PMID:38448586 |
None Available | GCST90270074 | Personality traits or cognitive traits (multivariate analysis) | 337,125 British ancestry individuals | ? | NR | 1E-36 | 36 | rs429358 | N/A | neuroticism measurement (EFO:0007660) cognitive function measurement (EFO:0008354) |
PMID:37365406 |
GWAS1006492_H | GCST90275041 | Nonalcoholic fatty liver disease | 6,623 European ancestry cases, 26,318 European ancestry controls | C | NR | 6E-16 | 15.222 | rs429358 | 0.88 | non-alcoholic fatty liver disease (EFO:0003095) |
PMID:37235137 |
None Available | GCST90275047 | Nonalcoholic fatty liver disease in overweight individuals (25<=BMI<=30) | 3,069 European ancestry cases, 10,641 European ancestry controls | C | NR | 1E-11 | 11 | rs429358 | 0.76 | non-alcoholic fatty liver disease (EFO:0003095) |
PMID:37235137 |
GWAS1006552_H | GCST90301995 | Total cholesterol in large HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8432 | 9E-73 | 72.046 | rs429358 | 0.1006 | total cholesterol change measurement (EFO:0007806) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:38448586 |
GWAS1006623_H | GCST90235979 | Forkhead box protein O1A level in Chronic kidney disease with hypertension and no diabetes (22055_31) | 466 African American individuals | C | 0.21 | 5E-29 | 28.302 | rs429358 | 0.81 | PMID:35870639 | |
GWAS1006752_H | GCST90302055 | Monounsaturated fatty acids (16:1, 18:1) levels | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.843 | 2E-73 | 72.699 | rs429358 | 0.1004 | fatty acid measurement (EFO:0005110) |
PMID:38448586 |
GWAS1006755_H | GCST90271929 | Nonalcoholic fatty liver disease | 2,757 European ancestry cases, 460,161 European ancestry controls | ? | NR | 5E-8 | 7.302 | rs429358 | N/A | non-alcoholic fatty liver disease (EFO:0003095) |
PMID:36986172 |
None Available | GCST90271817 | Serum Tau-C levels | 4,968 Danish ancestry individuals | ? | NR | 2E-11 | 10.699 | rs429358 | 0.12 | p-tau measurement (EFO:0004763) |
PMID:37357295 |
GWAS1006826_H | GCST90301993 | Triglyceride levels in LDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8431 | 2E-123 | 122.699 | rs429358 | 0.13 | triglyceride measurement (EFO:0004530) low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:38448586 |
None Available | GCST90235902 | Proteasome subunit beta type-10 level in Chronic kidney disease with hypertension and no diabetes (21861_8) | 466 African American individuals | C | 0.21 | 2E-13 | 12.699 | rs429358 | 0.57 | PMID:35870639 | |
GWAS1006913_H | GCST90233503 | Tubulin-specific chaperone A level in Chronic kidney disease with hypertension and no diabetes (12501_10) | 466 African American individuals | C | 0.21 | 1E-86 | 86 | rs429358 | 1.19 | PMID:35870639 | |
GWAS1006990_H | GCST90302108 | Free cholesterol in small VLDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.843 | 3E-95 | 94.523 | rs429358 | 0.1129 | free cholesterol in small VLDL measurement (EFO:0022272) |
PMID:38448586 |
None Available | GCST90302031 | Total cholesterol levels in medium HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8434 | 4E-82 | 81.398 | rs429358 | 0.1085 | total cholesterol measurement (EFO:0004574) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:38448586 |
None Available | GCST90302030 | Triglycerides to total lipids ratio in large VLDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8423 | 2E-21 | 20.699 | rs429358 | 0.0559 | triglycerides:total lipids ratio (EFO:0020947) very low density lipoprotein cholesterol measurement (EFO:0008317) |
PMID:38448586 |
None Available | GCST90234964 | Cytidine deaminase level in Chronic kidney disease with hypertension and no diabetes (18336_31) | 466 African American individuals | C | 0.21 | 6E-13 | 12.222 | rs429358 | 0.56 | cytidine measurement (EFO:0800645) |
PMID:35870639 |
None Available | GCST90239096 | Transmembrane and coiled-coil domains protein 3 level in Chronic kidney disease with hypertension and no diabetes (8922_4) | 466 African American individuals | C | 0.21 | 1E-14 | 14 | rs429358 | 0.59 | protein measurement (EFO:0004747) |
PMID:35870639 |
None Available | GCST90302118 | Total fatty acids | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.843 | 2E-123 | 122.699 | rs429358 | 0.1307 | fatty acid measurement (EFO:0005110) |
PMID:38448586 |
None Available | GCST90302120 | Tyrosine levels | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.843 | 2E-11 | 10.699 | rs429358 | 0.038 | tyrosine measurement (EFO:0005058) |
PMID:38448586 |
GWAS1007361_H | GCST90302032 | Total cholesterol to total lipids ratio in medium HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8434 | 5E-52 | 51.302 | rs429358 | 0.0841 | esterified cholesterol measurement (EFO:0008589) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:38448586 |
GWAS1007364_H | GCST90302033 | Cholesterol esters in medium HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8434 | 4E-89 | 88.398 | rs429358 | 0.1133 | esterified cholesterol measurement (EFO:0008589) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:38448586 |
GWAS1007522_H | GCST90302135 | Phospholipids to total lipids ratio in very large HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8432 | 2E-97 | 96.699 | rs429358 | 0.1168 | phospholipids:total lipids ratio (EFO:0020946) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:38448586 |
GWAS1007526_H | GCST90302136 | Triglycerides in very large HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8431 | 3E-41 | 40.523 | rs429358 | 0.0739 | triglycerides in very large HDL measurement (EFO:0022324) |
PMID:38448586 |
GWAS1007766_H | GCST90235567 | Pre-miRNA 5'-monophosphate methyltransferase level in Chronic kidney disease with hypertension and no diabetes (21115_48) | 466 African American individuals | C | 0.21 | 6E-46 | 45.222 | rs429358 | 0.97 | PMID:35870639 | |
GWAS1007842_H | GCST90301948 | 3-Hydroxybutyrate levels | 11,340 South Asian ancestry individuals, 72,076 European ancestry individuals | T | 0.8425 | 9E-20 | 19.046 | rs429358 | 0.0652 | 3-hydroxybutyrate measurement (EFO:0010982) |
PMID:38448586 |
None Available | GCST90236845 | Arginyl-tRNA--protein transferase 1 level in Chronic kidney disease with hypertension and no diabetes (25108_6) | 466 African American individuals | C | 0.21 | 9E-20 | 19.046 | rs429358 | 0.68 | PMID:35870639 | |
GWAS1008096_H | GCST90302164 | Cholesteryl ester levels in chylomicrons and extremely large VLDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8431 | 2E-84 | 83.699 | rs429358 | 0.1074 | cholesteryl ester measurement (EFO:0010351) chylomicron measurement (EFO:0008596) very low density lipoprotein cholesterol measurement (EFO:0008317) |
PMID:38448586 |
GWAS1008114_H | GCST90302101 | Triglycerides in small LDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8431 | 2E-127 | 126.699 | rs429358 | 0.1325 | triglycerides in small LDL measurement (EFO:0022323) |
PMID:38448586 |
GWAS1008297_H | GCST90018956 | HDL cholesterol | 315,133 European ancestry individuals, 74,970 East Asian ancestry individuals | C | NR | 2E-155 | 154.699 | rs429358 | 0.0773 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:34594039 |
GWAS1008334_H | GCST90233784 | Tumor protein p53-inducible protein 11 level in Chronic kidney disease with hypertension and no diabetes (13022_20) | 466 African American individuals | C | 0.21 | 6E-51 | 50.222 | rs429358 | 1.01 | PMID:35870639 | |
None Available | GCST90301971 | Total cholesterol levels in HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8432 | 2E-28 | 27.699 | rs429358 | 0.0617 | total cholesterol measurement (EFO:0004574) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:38448586 |
GWAS1008371_H | GCST90301969 | Total cholesterol in HDL2 | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8432 | 1E-40 | 40 | rs429358 | 0.0744 | total cholesterol measurement (EFO:0004574) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:38448586 |
GWAS1009331_H | GCST90428119 | Body mass index | 342,566 European ancestry individuals | C | NR | 6E-10 | 9.222 | rs429358 | 0.0205752 | body mass index (EFO:0004340) |
PMID:38538606 |
GWAS1010145_H | GCST90301997 | Cholesterol esters in large HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8432 | 2E-77 | 76.699 | rs429358 | 0.1039 | cholesterol esters in large HDL measurement (EFO:0022159) |
PMID:38448586 |
GWAS1011085_H | GCST90302012 | Free cholesterol to total lipids ratio in large LDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8431 | 5E-92 | 91.302 | rs429358 | 0.1139 | low density lipoprotein cholesterol measurement (EFO:0004611) free cholesterol:total lipids ratio (EFO:0020945) |
PMID:38448586 |
GWAS1012293_H | GCST90302006 | Triglycerides to total lipids ratio in large HDL | 4,435 East Asian ancestry individuals, 11,340 South Asian ancestry individuals, 120,241 European ancestry individuals | T | 0.8435 | 3E-28 | 27.523 | rs429358 | 0.0613 | triglycerides:total lipids ratio (EFO:0020947) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:38448586 |
None Available | GCST90319904 | Serum urate levels | 219,768 East Asian ancestry individuals, 677,373 European ancestry individuals, 132,182 individuals | T | NR | 6E-10 | 9.222 | rs429358 | 0.0198 | urate measurement (EFO:0004531) |
PMID:38658550 |
None Available | GCST90319906 | Serum urate levels | 677,373 European ancestry individuals | T | NR | 1E-8 | 8 | rs429358 | 0.0215 | urate measurement (EFO:0004531) |
PMID:38658550 |
None Available | GCST90000618 | Serum 25-Hydroxyvitamin D levels | 496,946 European ancestry individuals | ? | NR | 1E-15 | 15 | rs429358 | 0.0232636 | vitamin D measurement (EFO:0004631) |
PMID:32242144 |
GWAS1014736_H | GCST90016673 | Percent liver fat | 32,858 European ancestry individuals | ? | NR | 1E-30 | 30 | rs429358 | 0.123 | liver fat measurement (EFO:0010821) |
PMID:34128465 |
None Available | GCST90089008 | Serum levels of protein CKAP2 | 5,351 Icelandic ancestry individuals | C | 0.1528 | 4E-24 | 23.398 | rs429358 | 0.254682 | blood protein measurement (EFO:0007937) |
PMID:35078996 |
None Available | GCST90011296 | Executive function (trail making test B) | 78,547 British ancestry individuals | ? | NR | 2E-13 | 12.699 | rs429358 | N/A | executive function measurement (EFO:0009332) |
PMID:32895543 |
None Available | GCST90011297 | Information processing speed (symbol digit substitution) | 87,741 British ancestry individuals | ? | NR | 2E-18 | 17.699 | rs429358 | N/A | information processing speed (EFO:0004363) |
PMID:32895543 |
GWAS1015822_H | GCST011622 | Serum type 1 collagen metabolite levels | 4,891 Danish ancestry individuals | C | 0.16 | 1E-17 | 17 | rs429358 | 0.1619 | matrix metalloproteinase–degraded type I collagen measurement (EFO:0011036) |
PMID:33134509 |
GWAS1017328_H | GCST012482 | Cerebral amyloid angiopathy in APOEe4 carrier Alzheimer’s disease | 534 European ancestry individuals | C | 0.39 | 9E-16 | 15.046 | rs429358 | 0.32 | cerebral amyloid angiopathy (EFO:0006790) |
PMID:34020725 |
None Available | GCST90091061 | Cortical thickness | 35,657 White British ancestry individuals | C | 0.1526 | 5E-10 | 9.302 | rs429358 | N/A | cortical thickness (EFO:0004840) |
PMID:34560273 |
GWAS1017991_H | GCST90087352 | Serum levels of protein PSD | 5,348 Icelandic ancestry individuals | C | 0.1528 | 4E-52 | 51.398 | rs429358 | 0.371641 | blood protein measurement (EFO:0007937) |
PMID:35078996 |
GWAS1018013_H | GCST90087645 | Serum levels of protein CTF1 | 5,329 Icelandic ancestry individuals | C | 0.1528 | 3E-159 | 158.523 | rs429358 | 0.566759 | blood protein measurement (EFO:0007937) |
PMID:35078996 |
GWAS1018121_H | GCST90089238 | Serum levels of protein PSME1 | 5,352 Icelandic ancestry individuals | C | 0.1528 | 7E-32 | 31.155 | rs429358 | 0.301643 | blood protein measurement (EFO:0007937) |
PMID:35078996 |
None Available | GCST90088077 | Serum levels of protein APOB | 5,366 Icelandic ancestry individuals | C | 0.1528 | 3E-24 | 23.523 | rs429358 | 0.271148 | apolipoprotein B measurement (EFO:0004615) |
PMID:35078996 |
None Available | GCST90090811 | Serum levels of protein NDE1 | 5,363 Icelandic ancestry individuals | C | 0.1528 | 2E-91 | 90.699 | rs429358 | 0.51394 | blood protein measurement (EFO:0007937) |
PMID:35078996 |
GWAS1018215_H | GCST90088031 | Serum levels of protein AIMP1 | 5,349 Icelandic ancestry individuals | C | 0.1528 | 3E-53 | 52.523 | rs429358 | 0.372704 | blood protein measurement (EFO:0007937) |
PMID:35078996 |
None Available | GCST90088867 | Serum levels of protein MSN | 5,364 Icelandic ancestry individuals | C | 0.1528 | 2E-127 | 126.699 | rs429358 | 0.600298 | blood protein measurement (EFO:0007937) |
PMID:35078996 |
None Available | GCST90087869 | Serum levels of protein RALA | 5,366 Icelandic ancestry individuals | C | 0.1528 | 8E-13 | 12.097 | rs429358 | 0.188585 | blood protein measurement (EFO:0007937) |
PMID:35078996 |
None Available | GCST90088872 | Serum levels of protein PLA2G7 | 5,366 Icelandic ancestry individuals | C | 0.1528 | 2E-13 | 12.699 | rs429358 | 0.192497 | blood protein measurement (EFO:0007937) |
PMID:35078996 |
None Available | GCST90089380 | Serum levels of protein C5orf38 | 5,357 Icelandic ancestry individuals | C | 0.1528 | 1E-61 | 61 | rs429358 | 0.432082 | blood protein measurement (EFO:0007937) |
PMID:35078996 |
GWAS1018686_H | GCST90086204 | Serum levels of protein BIRC2 | 5,366 Icelandic ancestry individuals | C | 0.1528 | 3E-111 | 110.523 | rs429358 | 0.579285 | blood protein measurement (EFO:0007937) |
PMID:35078996 |
GWAS1018755_H | GCST90090956 | Serum levels of protein IRF6 | 5,367 Icelandic ancestry individuals | C | 0.1528 | 2E-186 | 185.699 | rs429358 | 0.716266 | blood protein measurement (EFO:0007937) |
PMID:35078996 |
None Available | GCST90089007 | Serum levels of protein CPE | 5,339 Icelandic ancestry individuals | C | 0.1528 | 2E-19 | 18.699 | rs429358 | 0.212236 | blood protein measurement (EFO:0007937) |
PMID:35078996 |
None Available | GCST90088668 | Serum levels of protein CRP | 5,368 Icelandic ancestry individuals | C | 0.1528 | 2E-23 | 22.699 | rs429358 | 0.268878 | blood protein measurement (EFO:0007937) |
PMID:35078996 |
None Available | GCST90090174 | Serum levels of protein YWHAE | 5,363 Icelandic ancestry individuals | C | 0.1528 | 5E-57 | 56.302 | rs429358 | 0.419172 | blood protein measurement (EFO:0007937) |
PMID:35078996 |
None Available | GCST90095659 | Entorhinal cortical thickness | 2,643 Korean ancestry individuals | C | 0.11 | 1E-9 | 9 | rs429358 | 0.25 | cortical thickness (EFO:0004840) |
PMID:34785643 |
None Available | GCST90095658 | Hippocampal volume | 2,643 Korean ancestry individuals | C | 0.11 | 1E-15 | 15 | rs429358 | 0.3 | hippocampal volume (EFO:0005035) |
PMID:34785643 |
None Available | GCST90095660 | Superior frontal cortical thickness | 2,643 Korean ancestry individuals | C | 0.11 | 1E-8 | 8 | rs429358 | 0.24 | cortical thickness (EFO:0004840) |
PMID:34785643 |
None Available | GCST90319532 | High-sensitivity C-reactive protein levels | 9,947 Han Chinese ancestry individuals, 294 individuals | C | NR | 3E-22 | 21.523 | rs429358 | 0.25 | C-reactive protein measurement (EFO:0004458) |
PMID:37479695 |
GWAS1020904_H | GCST90089065 | Serum levels of protein SNRPF | 5,356 Icelandic ancestry individuals | C | 0.1528 | 2E-76 | 75.699 | rs429358 | 0.453913 | blood protein measurement (EFO:0007937) |
PMID:35078996 |
None Available | GCST011941 | Plasma amyloid beta peptide concentrations (ABx-42) | 12,369 European ancestry non-demented individuals | C | 0.134 | 9E-13 | 12.046 | rs429358 | 0.167 | plasma beta-amyloid 1-42 measurement (EFO:0005660) |
PMID:34002480 |
None Available | GCST011943 | Plasma amyloid beta peptide concentration (ABx-40/ABx-42 ratio) | 12,369 European ancestry non-demented individuals | C | 0.134 | 6E-20 | 19.222 | rs429358 | 0.212 | plasma beta-amyloid 1-40:1-42 ratio measurement (EFO:0600016) |
PMID:34002480 |
None Available | GCST90027237 | Plasma p-tau181 levels | 1,153 European ancestry individuals | ? | NR | 3E-25 | 24.523 | rs429358 | 0.281 | p-tau measurement (EFO:0004763) |
PMID:34119372 |
None Available | GCST012419 | Longevity (100 years and older) | 1,320 European ancestry cases, 2,899 European ancestry controls | C | 0.138 | 3E-28 | 27.523 | rs429358 | 11.02543 | longevity (EFO:0004300) |
PMID:33948810 |
GWAS1022572_H | GCST90038451 | Alzheimer's disease | 4,010 European ancestry cases, 4,672 European ancestry controls | C | 0.226 | 5E-122 | 121.302 | rs429358 | 3.245 | PMID:34122051 | |
GWAS1022573_H | GCST90038452 | Alzheimer's disease | 5,705 European ancestry cases, 7,067 European ancestry controls | C | 0.216 | 2E-215 | 214.699 | rs429358 | 3.655 | PMID:34122051 | |
None Available | GCST90054782 | Nonalcoholic fatty liver disease | 4,761 European ancestry cases, 373,227 European ancestry controls | C | 0.156 | 3E-13 | 12.523 | rs429358 | 0.82 | non-alcoholic fatty liver disease (EFO:0003095) |
PMID:34535985 |
GWAS1024260_H | GCST90026487 | Alzheimer's disease | 622 cases, 366 controls | ? | NR | 5E-36 | 35.302 | rs429358 | 4.348 | PMID:34336000 | |
GWAS1025405_H | GCST90085710 | Apo E plasma levels | 400 French ancestry individuals | T | NR | 4E-9 | 8.398 | rs429358 | 0.233 | apolipoprotein E measurement (EFO:0008029) |
PMID:35264221 |
None Available | GCST90013405 | Liver enzyme levels (alanine transaminase) | 437,267 European ancestry individuals | T | 0.845488 | 1E-56 | 56 | rs429358 | 0.0085211 | serum alanine aminotransferase measurement (EFO:0004735) |
PMID:33972514 |
GWAS1025599_H | GCST90013406 | Liver enzyme levels (alkaline phosphatase) | 437,438 European ancestry individuals | T | 0.845457 | 8E-40 | 39.097 | rs429358 | 0.00415406 | alkaline phosphatase measurement (EFO:0004533) |
PMID:33972514 |
None Available | GCST90161240 | Hip fracture | 11,516 European ancestry cases, 723,838 European ancestry controls | C | 0.17 | 4E-11 | 10.398 | rs429358 | 1.14 | hip fracture (EFO:0003964) |
PMID:36260985 |
None Available | GCST90239729 | Brain morphology (MOSTest) | 33,735 white British ancestry individuals | ? | NR | 1E-9 | 9 | rs429358 | N/A | neuroimaging measurement (EFO:0004346) |
PMID:35164939 |
GWAS1026240_H | GCST90250832 | Age-related macular degeneration or COVID-19 critical illness (MTAG) | 16,144 European ancestry AMD cases, 5,101 European ancestry COVID-19 critical illness cases, 1,401,064 European ancestry controls | ? | NR | 1E-44 | 44 | rs429358 | 0.17 | age-related macular degeneration (EFO:0001365) |
PMID:36614910 |
None Available | GCST90165317 | Node-level brain connectivity (multivariate analysis) | 30,810 British ancestry individuals | T | 0.847988 | 9E-10 | 9.046 | rs429358 | 6.1278005 | brain connectivity measurement (EFO:0005210) |
PMID:36800424 |
None Available | GCST90162547 | Common executive function | 427,037 European ancestry individuals | ? | NR | 1E-19 | 19 | rs429358 | N/A | executive function measurement (EFO:0009332) |
PMID:36150907 |
GWAS1029139_H | GCST90244976 | 1-stearoyl-GPE (18:0) levels | 14,296 European ancestry individuals | T | 0.8452 | 8E-19 | 18.097 | rs429358 | 0.12185323 | 1-stearoyl-GPE (18:0) measurement (EFO:0800227) |
PMID:36357675 |
None Available | GCST90244950 | 1-palmitoyl-2-stearoyl-gpc (16:0/18:0) levels | 14,296 European ancestry individuals | T | 0.845 | 7E-19 | 18.155 | rs429358 | 0.12448824 | 1-palmitoyl-2-stearoyl-GPC (16:0/18:0) measurement (EFO:0800396) |
PMID:36357675 |
None Available | GCST90244654 | High density lipoprotein cholesterol levels | 29,502 European ancestry individuals, 16,983 Black individuals, 13,943 Hispanic individuals, 4,719 Asian ancestry individuals, 1,182 Samoan ancestry individuals | ? | NR | 8E-40 | 39.097 | rs429358 | 1.6491529 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:36220816 |
GWAS1029213_H | GCST90250834 | Age-related macular degeneration or COVID-19 infection (MTAG) | 16,144 European ancestry AMD cases, 38,984 European ancestry COVID-19 infection cases, 1,662,607 European ancestry controls | ? | NR | 2E-44 | 43.699 | rs429358 | 0.17 | age-related macular degeneration (EFO:0001365) |
PMID:36614910 |
None Available | GCST90131903 | Insomnia | 390,751 European ancestry female cases, 1,018,386 European ancestry female controls | T | NR | 6E-9 | 8.222 | rs429358 | 0.01 | insomnia (EFO:0004698) |
PMID:35835914 |
None Available | GCST90245425 | Sphingomyelin (d18:2/14:0, d18:1/14:1) levels | 14,296 European ancestry individuals | T | 0.8453 | 1E-10 | 10 | rs429358 | 0.08893802 | Sphingomyelin (d18:2/14:0, d18:1/14:1) measurement (EFO:0022114) |
PMID:36357675 |
None Available | GCST90245426 | Sphingomyelin (d18:2/16:0, d18:1/16:1) levels | 14,296 European ancestry individuals | T | 0.8452 | 4E-9 | 8.398 | rs429358 | 0.081198804 | Sphingomyelin (d18:2/16:0, d18:1/16:1) measurement (EFO:0022115) |
PMID:36357675 |
None Available | GCST90244565 | Body mass index (aged 64-69 years) | 85,009 European ancestry individuals | ? | NR | 2E-14 | 13.699 | rs429358 | 0.2246 | body mass index (EFO:0004340) |
PMID:36276968 |
None Available | GCST90244566 | Body fat percentage (aged 64-69 years) | 83,345 European ancestry individuals | C | NR | 1E-15 | 15 | rs429358 | 0.325 | body fat percentage (EFO:0007800) |
PMID:36276968 |
None Available | GCST90244567 | Waist-hip ratio (aged 64-69 years) | 85,152 European ancestry individuals | C | NR | 4E-15 | 14.398 | rs429358 | 0.0035 | waist-hip ratio (EFO:0004343) |
PMID:36276968 |
None Available | GCST90244568 | Waist circumference (aged 64-69 years) | 85,157 European ancestry individuals | ? | NR | 1E-16 | 16 | rs429358 | 0.635 | waist circumference (EFO:0004342) |
PMID:36276968 |
None Available | GCST90244569 | Hip circumference (aged 64-69 years) | 85,156 European ancestry individuals | ? | NR | 4E-8 | 7.398 | rs429358 | 0.3191 | hip circumference (EFO:0005093) |
PMID:36276968 |
GWAS1029436_H | GCST90245341 | N-palmitoyl-sphingosine (d18:1/16:0) levels | 14,296 European ancestry individuals | T | 0.8452 | 1E-26 | 26 | rs429358 | 0.1474476 | N-palmitoyl-sphingosine (d18:1/16:0) measurement (EFO:0800607) |
PMID:36357675 |
GWAS1029470_H | GCST90250902 | Medication use for hyperlipidemia (number of purchases) | 567,671 European ancestry individuals | ? | NR | 1E-308 | 308 | rs429358 | 0.070676 | antihyperlipidemic drug use measurement (EFO:0803367) |
PMID:36653479 |
None Available | GCST90179147 | High-density lipoprotein levels (MTAG) | 361,194 European ancestry individuals | T | NR | 2E-19 | 18.699 | rs429358 | 0.03274 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:36376304 |
GWAS1029890_H | GCST90267352 | Liver proton density fat fraction | 33,235 European ancestry individuals | C | 0.16 | 2E-29 | 28.699 | rs429358 | 11.26 | liver fat measurement (EFO:0010821) |
PMID:36402844 |
None Available | GCST90032648 | Relative carbohydrate intake | 282,271 European ancestry individuals | T | 0.848 | 2E-8 | 7.699 | rs429358 | 0.1863 | carbohydrate intake measurement (EFO:0010811) |
PMID:34426670 |
None Available | GCST90267367 | Body composition (MOSTest) | 33,588 European ancestry individuals | ? | NR | 7E-31 | 30.155 | rs429358 | 11.56 | body composition measurement (EFO:0005106) |
PMID:36402844 |
GWAS1030108_H | GCST90179211 | Phospholipids to total lipids ratio in small LDL | 7,142 European ancestry individuals | T | 0.15 | 5E-33 | 32.302 | rs429358 | 0.27 | low density lipoprotein cholesterol measurement (EFO:0004611) phospholipids:total lipids ratio (EFO:0020946) |
PMID:32150548 |
None Available | GCST90250833 | Age-related macular degeneration or COVID-19 hospitalization (MTAG) | 16,144 European ancestry AMD cases, 9,986 European ancestry COVID-19 hospitalization cases, 1,895,495 European ancestry controls | ? | NR | 2E-44 | 43.699 | rs429358 | 0.17 | age-related macular degeneration (EFO:0001365) |
PMID:36614910 |
None Available | GCST90244924 | 1-nonadecanoyl-GPC (19:0) levels | 14,296 European ancestry individuals | T | 0.8445 | 1E-13 | 13 | rs429358 | 0.10511124 | 1-nonadecanoyl-GPC (19:0) measurement (EFO:0800357) |
PMID:36357675 |
None Available | GCST90102753 | 1-stearoyl-2-linoleoyl-GPE (18:0/18:2) levels | 8,809 European ancestry individuals | C | NR | 4E-11 | 10.398 | rs429358 | 0.137 | 1-stearoyl-2-linoleoyl-GPE (18:0/18:2) measurement (EFO:0800402) |
PMID:35050183 |
None Available | GCST90044699 | Late-onset Alzheimer's disease | 43,725 European ancestry cases, 46,613 European ancestry proxy cases, 1,036,225 European ancestry controls | ? | NR | 1E-300 | 300 | rs429358 | N/A | late-onset Alzheimers disease (EFO:1001870) |
PMID:34493870 |
None Available | GCST90133316 | Age of onset of parkinson disease | 7,847 European ancestry individuals, 688 East Asian ancestry individuals, 17,415 individuals | T | 0.866 | 0.000001 | 6 | rs429358 | 0.695 | PMID:35970579 | |
GWAS1035423_H | GCST90244793 | Dyslipidemia | 15,054 Korean ancestry cases, 37,395 Korean ancestry controls | C | 0.09561 | 2E-31 | 30.699 | rs429358 | 1.298 | PMID:36419087 | |
GWAS1036286_H | GCST90244026 | Alzheimer's disease | 386 European ancestry cases, 2,206 European ancestry controls | C | 0.1099 | 9E-14 | 13.046 | rs429358 | 2.217 | PMID:35694926 | |
None Available | GCST90244027 | Alzheimer's disease | 182 European ancestry female cases, 978 European ancestry female controls | ? | NR | 2E-10 | 9.699 | rs429358 | 2.722 | PMID:35694926 | |
None Available | GCST90244029 | Dementia | 424 European ancestry cases, 2,206 European ancestry controls | C | 0.1099 | 2E-12 | 11.699 | rs429358 | 2.086 | PMID:35694926 | |
GWAS1036287_H | GCST90244030 | Dementia | 203 European ancestry female cases, 978 European ancestry female controls | ? | NR | 3E-10 | 9.523 | rs429358 | 2.582 | PMID:35694926 | |
None Available | GCST90104755 | COVID-19 (severe vs population) | 1,120 European ancestry cases, 458,130 European ancestry controls, 124 cases, 27,946 controls | C | 0.15406817 | 1E-7 | 7 | rs429358 | 0.30173 | PMID:35224516 | |
None Available | GCST90104761 | COVID-19 (severe vs tested, not severe) | 1,120 European ancestry cases, 79,439 European ancestry controls, 124 cases, 5,303 controls | C | 0.15463564 | 4E-7 | 6.398 | rs429358 | 0.29009 | PMID:35224516 | |
GWAS1037060_H | GCST90134519 | HDL cholesterol levels | 58,701 Korean ancestry individuals | C | NR | 1E-46 | 46 | rs429358 | 1.78 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:35884923 |
GWAS1037081_H | GCST90428729 | Alanine aminotransferase levels | 1,010,710 European ancestry individuals | C | NR | 2E-61 | 60.699 | rs429358 | 0.0088 | serum alanine aminotransferase measurement (EFO:0004735) |
PMID:38632349 |
GWAS1037515_H | GCST90278635 | High density lipoprotein cholesterol levels | 92,615 Taiwanese ancestry individuals | ? | NR | 6E-56 | 55.222 | rs429358 | N/A | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:38116116 |
None Available | GCST90428730 | Gamma glutamyl transferase levels | 875,069 European ancestry individuals | C | NR | 2E-14 | 13.699 | rs429358 | 0.0054 | serum gamma-glutamyl transferase measurement (EFO:0004532) |
PMID:38632349 |
None Available | GCST90100667 | Apolipoprotein E (isoform E2) levels | 997 European ancestry individuals | ? | NR | 2E-12 | 11.699 | rs429358 | N/A | apolipoprotein E isoform E2 measurement (EFO:0008028) |
PMID:28240269 |
GWAS1039378_H | GCST90018943 | Alanine aminotransferase levels | 344,136 European ancestry individuals, 150,545 East Asian ancestry individuals | C | NR | 4E-40 | 39.398 | rs429358 | 0.0359 | serum alanine aminotransferase measurement (EFO:0004735) |
PMID:34594039 |
None Available | GCST90161353 | Apolipoprotein E levels | 2,935 Qatari ancestry individuals | C | 0.0817717 | 1E-18 | 18 | rs429358 | 0.43479 | apolipoprotein E measurement (EFO:0008029) |
PMID:36168886 |
GWAS1040239_H | GCST90428732 | Gall stone disease or coronary artery disease | 43,639 European ancestry gall stone disease cases, 181,522 European ancestry coronary artery disease cases, 1,490,966 European ancestry controls | ? | NR | 4E-47 | 46.398 | rs429358 | N/A | gallstones (EFO:0004210) coronary artery disease (EFO:0001645) |
PMID:37705021 |
GWAS1040737_H | GCST90137693 | Apolipoprotein E (isoform E3) levels | 1,852 African American or Afro-Caribbean individuals | ? | NR | 1E-34 | 34 | rs429358 | 0.42 | apolipoprotein E (isoform E3) measurement (EFO:0020157) |
PMID:34814699 |
GWAS1041050_H | GCST90137694 | Apolipoprotein E (isoform E4) levels | 1,852 African American or Afro-Caribbean individuals | ? | NR | 8E-29 | 28.097 | rs429358 | 0.38 | apolipoprotein E (isoform E4) measurement (EFO:0020158) |
PMID:34814699 |
None Available | GCST90161481 | Stromelysin-1 levels | 2,935 Qatari ancestry individuals | C | 0.0817717 | 1E-15 | 15 | rs429358 | 0.394747 | stromelysin‐1 measurement (EFO:0010608) |
PMID:36168886 |
None Available | GCST90137939 | Neutrophil collagenase levels | 1,852 African American or Afro-Caribbean individuals | ? | NR | 5E-35 | 34.302 | rs429358 | 0.45 | matrix metalloproteinase 8 measurement (EFO:0008466) |
PMID:34814699 |
None Available | GCST90018793 | Angina pectoris | 30,025 European ancestry cases, 440,906 European ancestry controls, 14,007 East Asian ancestry cases, 145,158 East Asian ancestry controls | C | NR | 1E-16 | 16 | rs429358 | 0.0937 | angina pectoris (EFO:0003913) |
PMID:34594039 |
None Available | GCST90399695 | Chronic obstructive pulmonary disease | 1,503 Admixed American ancestry cases, 13,583 Admixed American ancestry controls, 484 South Asian ancestry cases, 21,464 South Asian ancestry controls, 1,978 African ancestry cases, 27,704 African ancestry controls, 19,044 East Asian ancestry cases, 310,689 East Asian ancestry controls, 58,559 European ancestry cases, 937,358 European ancestry controls | C | 0.1398 | 1E-8 | 8 | rs429358 | 0.049172 | chronic obstructive pulmonary disease (EFO:0000341) |
PMID:36777996 |
None Available | GCST90134472 | Alanine aminotransferase levels | 5,694 African ancestry individuals, 1,988 East Asian ancestry individuals, 336,298 European ancestry individuals, 6,036 South Asian ancestry individuals | ? | NR | 2E-24 | 23.699 | rs429358 | N/A | serum alanine aminotransferase measurement (EFO:0004735) |
PMID:35810165 |
None Available | GCST90137536 | Apolipoprotein E levels | 1,852 African American or Afro-Caribbean individuals | ? | NR | 1E-39 | 39 | rs429358 | 0.45 | apolipoprotein E measurement (EFO:0008029) |
PMID:34814699 |
GWAS1043521_H | GCST90137537 | Apolipoprotein E (isoform E2) levels | 1,852 African American or Afro-Caribbean individuals | ? | NR | 5E-43 | 42.302 | rs429358 | 0.47 | apolipoprotein E isoform E2 measurement (EFO:0008028) |
PMID:34814699 |
GWAS1043839_H | GCST90132184 | Type 2 diabetes | 251,740 European ancestry individuals | T | 0.847 | 3E-15 | 14.523 | rs429358 | 0.072 | PMID:35551307 | |
None Available | GCST90020027 | Waist-hip index | 219,872 British ancestry women | C | NR | 4E-11 | 10.398 | rs429358 | 0.0257463 | BMI-adjusted waist-hip ratio (EFO:0007788) |
PMID:34021172 |
None Available | GCST90277248 | Sterol ester (27:1/20:2) levels | 5,848 Finnish ancestry individuals | C | 0.189202 | 9E-12 | 11.046 | rs429358 | 0.162093 | PMID:37907536 | |
None Available | GCST90095131 | Vertex-wise cortical thickness | 33,748 European ancestry individuals | C | 0.16 | 5E-12 | 11.302 | rs429358 | 6.91 | cortical thickness (EFO:0004840) |
PMID:34910505 |
None Available | GCST90094794 | Liver liking | 158,306 European ancestry individuals | C | 0.1486 | 5E-13 | 12.302 | rs429358 | 0.10338 | taste liking measurement (EFO:0010155) |
PMID:35585065 |
None Available | GCST90094732 | Chicken liking | 158,559 European ancestry individuals | C | 0.1486 | 4E-8 | 7.398 | rs429358 | 0.02748 | taste liking measurement (EFO:0010155) |
PMID:35585065 |
None Available | GCST90094751 | F-dairy liking (derived food-liking factor) | 159,365 European ancestry individuals | C | 0.1487 | 3E-11 | 10.523 | rs429358 | 0.05312 | taste liking measurement (EFO:0010155) |
PMID:35585065 |
GWAS1044524_H | GCST90094761 | F-fatty food liking (derived food-liking factor) | 159,481 European ancestry individuals | C | 0.1486 | 8E-9 | 8.097 | rs429358 | 0.02885 | taste liking measurement (EFO:0010155) |
PMID:35585065 |
GWAS1044525_H | GCST90094725 | F-carbohydrate liking (derived food-liking factor) | 159,523 European ancestry individuals | C | 0.1486 | 6E-15 | 14.222 | rs429358 | 0.15209 | taste liking measurement (EFO:0010155) |
PMID:35585065 |
GWAS1044852_H | GCST90132314 | Coronary artery disease | 181,522 European ancestry, unknown cases, 984,168 European ancestry, unknown controls | T | 0.848 | 4E-38 | 37.398 | rs429358 | 0.913 | coronary artery disease (EFO:0001645) |
PMID:36474045 |
None Available | GCST90104598 | Nonalcoholic fatty liver disease | 3,711 European ancestry cases, 426,252 European ancestry controls | T | NR | 5E-8 | 7.302 | rs429358 | 0.2 | non-alcoholic fatty liver disease (EFO:0003095) |
PMID:35124268 |
None Available | GCST90103635 | Estimated glomerular filtration rate (cystatin c) | 460,826 European or unknown ancestry individuals | T | 0.8456 | 3E-18 | 17.523 | rs429358 | 0.0056 | glomerular filtration rate (EFO:0005208) |
PMID:34272381 |
None Available | GCST90018977 | Serum uric acid levels | 343,836 European ancestry individuals, 129,405 East Asian ancestry individuals | C | NR | 6E-13 | 12.222 | rs429358 | 0.0182 | uric acid measurement (EFO:0004761) |
PMID:34594039 |
GWAS1046528_H | GCST90018979 | Serum creatinine levels | 344,104 European ancestry individuals, 150,266 East Asian ancestry individuals | C | NR | 5E-28 | 27.302 | rs429358 | 0.0256 | creatinine measurement (EFO:0004518) |
PMID:34594039 |
GWAS1046808_H | GCST90161542 | Apolipoprotein E (isoform E3) levels | 2,935 Qatari ancestry individuals | C | 0.0817717 | 8E-20 | 19.097 | rs429358 | 0.448356 | apolipoprotein E (isoform E3) measurement (EFO:0020157) |
PMID:36168886 |
None Available | GCST90161543 | Apolipoprotein E (isoform E4) levels | 2,935 Qatari ancestry individuals | C | 0.0817717 | 2E-19 | 18.699 | rs429358 | 0.444119 | apolipoprotein E (isoform E4) measurement (EFO:0020158) |
PMID:36168886 |
GWAS1047191_H | GCST90239649 | High density lipoprotein cholesterol levels | 40,963 South Asian ancestry individuals, 48,057 Hispanic individuals, 99,432 Admixed African or African ancestry individuals, 146,492 East Asian ancestry individuals, 1,320,016 European ancestry individuals | ? | NR | 1E-497 | 497 | rs429358 | N/A | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:34887591 |
GWAS1047200_H | GCST90129599 | Cerebrospinal fluid amyloid beta 42 levels | 8,074 European ancestry individuals | C | 0.29 | 1E-379 | 379 | rs429358 | 41.68 | amyloid-beta measurement (EFO:0005194) |
PMID:36066633 |
GWAS1047202_H | GCST90129600 | Cerebrospinal fluid p-tau levels | 7,798 European ancestry individuals | C | 0.28 | 1E-94 | 94 | rs429358 | 20.65 | p-tau measurement (EFO:0004763) |
PMID:36066633 |
None Available | GCST90134628 | Cerebrospinal fluid amyloid beta 42 levels in APOE e4 carriers | 3,240 European ancestry individuals | C | 0.61 | 9E-72 | 71.046 | rs429358 | 17.918 | amyloid-beta measurement (EFO:0005194) |
PMID:36066633 |
GWAS1047205_H | GCST90134629 | Cerebrospinal fluid amyloid beta 42 levels in normal amyloid levels | 3,182 European ancestry individuals | C | 0.17 | 1E-47 | 47 | rs429358 | 14.49 | amyloid-beta measurement (EFO:0005194) |
PMID:36066633 |
None Available | GCST90134633 | Cerebrospinal fluid p-tau levels in normal amyloid levels | 3,174 European ancestry individuals | C | 0.17 | 2E-17 | 16.699 | rs429358 | 8.528 | p-tau measurement (EFO:0004763) |
PMID:36066633 |
None Available | GCST90094835 | F-savour/caloric food liking (derived food-liking factor) | 158,684 European ancestry individuals | C | 0.1486 | 1E-23 | 23 | rs429358 | 0.16206 | taste liking measurement (EFO:0010155) |
PMID:35585065 |
GWAS1047483_H | GCST90103633 | Estimated glomerular filtration rate (creatinine) | 1,004,040 European ancestry individuals, 165,726 East Asian ancestry individuals, 13,842 African American individuals, 13,359 South Asian ancestry individuals, 4,961 Hispanic individuals, 2 individuals | T | 0.845375880615863 | 7E-26 | 25.155 | rs429358 | 0.0029 | glomerular filtration rate (EFO:0005208) |
PMID:34272381 |
GWAS1047505_H | GCST90239652 | High density lipoprotein cholesterol levels | 1,320,016 European ancestry individuals | C | 0.151897 | 6E-256 | 255.222 | rs429358 | 0.0861765 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:34887591 |
GWAS1047638_H | GCST90094821 | Roast chicken liking | 158,556 European ancestry individuals | C | 0.1486 | 2E-9 | 8.699 | rs429358 | 0.05908 | taste liking measurement (EFO:0010155) |
PMID:35585065 |
None Available | GCST90094836 | F-seafood liking (derived food-liking factor) | 156,740 European ancestry individuals | C | 0.1486 | 6E-9 | 8.222 | rs429358 | 0.08124 | taste liking measurement (EFO:0010155) |
PMID:35585065 |
None Available | GCST90094819 | Red meat liking | 158,624 European ancestry individuals | C | 0.1486 | 1E-16 | 16 | rs429358 | 0.0415 | taste liking measurement (EFO:0010155) |
PMID:35585065 |
None Available | GCST90162367 | Apolipoprotein E (isoform E2) levels | 2,935 Qatari ancestry individuals | C | 0.0817717 | 1E-30 | 30 | rs429358 | 0.566227 | apolipoprotein E isoform E2 measurement (EFO:0008028) |
PMID:36168886 |
None Available | GCST90239651 | High density lipoprotein cholesterol levels | 146,492 East Asian ancestry individuals | C | 0.0933232 | 1E-47 | 47 | rs429358 | 0.114308 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:34887591 |
None Available | GCST90094700 | Beef/steak liking | 158,442 European ancestry individuals | C | 0.1486 | 5E-16 | 15.302 | rs429358 | 0.04074 | taste liking measurement (EFO:0010155) |
PMID:35585065 |
None Available | GCST90094698 | BBQ/grilled meat liking | 158,387 European ancestry individuals | C | 0.1486 | 5E-19 | 18.302 | rs429358 | 0.04474 | taste liking measurement (EFO:0010155) |
PMID:35585065 |
GWAS1048236_H | GCST90132183 | Type 2 diabetes | 251,740 European ancestry individuals, 139,705 East Asian ancestry individuals, 40,737 South Asian ancestry individuals, 27,417 Hispanic individuals, 30,167 African American individuals, 2,426 Zulu ancestry individuals | T | NR | 7E-14 | 13.155 | rs429358 | 1.06 | PMID:35551307 | |
None Available | GCST90131901 | Insomnia | 593,724 European ancestry cases, 1,771,286 European ancestry controls | T | NR | 2E-12 | 11.699 | rs429358 | 0.009 | insomnia (EFO:0004698) |
PMID:35835914 |
None Available | GCST90103632 | Blood urea nitrogen levels | 679,531 European ancestry individuals, 173,149 individuals | T | 0.8506 | 9E-10 | 9.046 | rs429358 | 0.0043 | blood urea nitrogen measurement (EFO:0004741) |
PMID:34272381 |
None Available | GCST90277244 | Sterol ester (27:1/18:0) levels | 7,157 Finnish ancestry individuals | C | 0.189202 | 5E-10 | 9.302 | rs429358 | 0.133624 | PMID:37907536 | |
GWAS1048865_H | GCST90094799 | F-meat liking (derived food-liking factor) | 158,509 European ancestry individuals | C | 0.1486 | 4E-23 | 22.398 | rs429358 | 0.16691 | taste liking measurement (EFO:0010155) |
PMID:35585065 |
None Available | GCST90094790 | Lamb liking | 158,453 European ancestry individuals | C | 0.1487 | 2E-12 | 11.699 | rs429358 | 0.03535 | taste liking measurement (EFO:0010155) |
PMID:35585065 |
None Available | GCST90277242 | Sterol ester (27:1/17:0) levels | 7,047 Finnish ancestry individuals | C | 0.189202 | 2E-8 | 7.699 | rs429358 | 0.121765 | PMID:37907536 | |
None Available | GCST90277238 | Sterol ester (27:1/14:0) levels | 7,174 Finnish ancestry individuals | C | 0.189202 | 4E-11 | 10.398 | rs429358 | 0.141695 | PMID:37907536 | |
None Available | GCST90435415 | Systolic blood pressure | 404,507 European ancestry individuals | ? | NR | 8E-11 | 10.097 | rs429358 | 0.0172603 | systolic blood pressure (EFO:0006335) |
PMID:39134668 |
None Available | GCST90435413 | Body mass index | 403,610 European ancestry individuals | ? | NR | 4E-21 | 20.398 | rs429358 | 0.0269316 | body mass index (EFO:0004340) |
PMID:39134668 |
None Available | GCST90091737 | Postprandial total cholesterol in small LDL | null | C | 0.162323441 | 1E-23 | 23 | rs429358 | 0.288119 | low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091741 | Postprandial small LDL particle concentration | null | C | 0.162323441 | 3E-24 | 23.523 | rs429358 | 0.29204 | low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091742 | Postprandial phospholipid levels in small LDL | null | C | 0.162323441 | 1E-22 | 22 | rs429358 | 0.281664 | low density lipoprotein cholesterol measurement (EFO:0004611) phospholipid measurement (EFO:0004639) |
PMID:34610981 |
None Available | GCST90091701 | Postprandial total cholesterol in medium HDL | null | C | 0.162323441 | 5E-10 | 9.302 | rs429358 | 0.179913 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:34610981 |
None Available | GCST90091702 | Postprandial cholesterol esters in medium HDL | null | C | 0.162323441 | 2E-10 | 9.699 | rs429358 | 0.183513 | esterified cholesterol measurement (EFO:0008589) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:34610981 |
None Available | GCST90091703 | Postprandial free cholesterol in medium HDL | null | C | 0.162323441 | 1E-8 | 8 | rs429358 | 0.165019 | free cholesterol measurement (EFO:0008591) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:34610981 |
None Available | GCST90091704 | Postprandial total lipids in medium HDL | null | C | 0.162323441 | 1E-9 | 9 | rs429358 | 0.176055 | lipid measurement (EFO:0004529) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:34610981 |
None Available | GCST90091608 | Fasting total lipids in small VLDL | null | C | 0.161548128 | 3E-13 | 12.523 | rs429358 | 0.202751 | very low density lipoprotein cholesterol measurement (EFO:0008317) lipid measurement (EFO:0004529) |
PMID:34610981 |
None Available | GCST90091609 | Fasting small VLDL particle concentration | null | C | 0.161548128 | 1E-12 | 12 | rs429358 | 0.196494 | very low density lipoprotein cholesterol measurement (EFO:0008317) |
PMID:34610981 |
None Available | GCST90091610 | Fasting phospholipid levels in small VLDL | null | C | 0.161548128 | 9E-12 | 11.046 | rs429358 | 0.189076 | very low density lipoprotein cholesterol measurement (EFO:0008317) phospholipid measurement (EFO:0004639) |
PMID:34610981 |
None Available | GCST90091573 | Fasting phospholipid levels in medium LDL | null | C | 0.161622913 | 2E-28 | 27.699 | rs429358 | 0.305241 | low density lipoprotein cholesterol measurement (EFO:0004611) phospholipid measurement (EFO:0004639) |
PMID:34610981 |
None Available | GCST90091783 | Postprandial cholesterol esters in chylomicrons and extremely large VLDL | null | C | 0.165453761 | 7E-9 | 8.155 | rs429358 | 0.169466 | chylomicron measurement (EFO:0008596) very low density lipoprotein cholesterol measurement (EFO:0008317) esterified cholesterol measurement (EFO:0008589) |
PMID:34610981 |
None Available | GCST90091743 | Postprandial triglycerides levels in small LDL | null | C | 0.162323441 | 4E-11 | 10.398 | rs429358 | 0.190428 | low density lipoprotein triglyceride measurement (EFO:0009946) |
PMID:34610981 |
None Available | GCST90091705 | Postprandial medium HDL particle concentration | null | C | 0.162323441 | 1E-9 | 9 | rs429358 | 0.1758 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:34610981 |
None Available | GCST90091721 | Postprandial phospholipid levels in medium VLDL | null | C | 0.162286109 | 2E-8 | 7.699 | rs429358 | 0.161577 | very low density lipoprotein cholesterol measurement (EFO:0008317) phospholipid measurement (EFO:0004639) |
PMID:34610981 |
None Available | GCST90091600 | Fasting total lipids in small LDL | null | C | 0.161585113 | 7E-27 | 26.155 | rs429358 | 0.296182 | low density lipoprotein cholesterol measurement (EFO:0004611) lipid measurement (EFO:0004529) |
PMID:34610981 |
None Available | GCST90091601 | Fasting small LDL particle concentration | null | C | 0.161585113 | 5E-27 | 26.302 | rs429358 | 0.296908 | low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091602 | Fasting phospholipid levels in small LDL | null | C | 0.161585113 | 4E-26 | 25.398 | rs429358 | 0.291909 | low density lipoprotein cholesterol measurement (EFO:0004611) phospholipid measurement (EFO:0004639) |
PMID:34610981 |
None Available | GCST90091671 | Postprandial IDL particle concentration | null | C | 0.162286109 | 3E-23 | 22.523 | rs429358 | 0.285903 | intermediate density lipoprotein measurement (EFO:0008595) |
PMID:34610981 |
None Available | GCST90091635 | Fasting total cholesterol in very small VLDL | null | C | 0.161800085 | 6E-18 | 17.222 | rs429358 | 0.23843 | very low density lipoprotein cholesterol measurement (EFO:0008317) |
PMID:34610981 |
None Available | GCST90091574 | Fasting triglycerides levels in medium LDL | null | C | 0.161622913 | 1E-11 | 11 | rs429358 | 0.18747 | low density lipoprotein triglyceride measurement (EFO:0009946) |
PMID:34610981 |
None Available | GCST90091725 | Postprandial polyunsaturated fatty acids | null | C | 0.162416939 | 9E-18 | 17.046 | rs429358 | 0.249076 | polyunsaturated fatty acid measurement (EFO:0010733) |
PMID:34610981 |
None Available | GCST90091708 | Postprandial total cholesterol in medium LDL | null | C | 0.162323441 | 2E-24 | 23.699 | rs429358 | 0.293495 | low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091585 | Fasting polyunsaturated fatty acids | null | C | 0.161647532 | 3E-20 | 19.523 | rs429358 | 0.255085 | polyunsaturated fatty acid measurement (EFO:0010733) |
PMID:34610981 |
None Available | GCST90091586 | Fasting remnant cholesterol | null | C | 0.161731728 | 2E-24 | 23.699 | rs429358 | 0.281063 | remnant cholesterol measurement (EFO:0010815) |
PMID:34610981 |
None Available | GCST90091587 | Fasting serum total cholesterol | null | C | 0.161731728 | 4E-21 | 20.398 | rs429358 | 0.260759 | total cholesterol measurement (EFO:0004574) |
PMID:34610981 |
None Available | GCST90091636 | Fasting cholesterol esters in very small VLDL | null | C | 0.161800085 | 2E-17 | 16.699 | rs429358 | 0.234638 | very low density lipoprotein cholesterol measurement (EFO:0008317) esterified cholesterol measurement (EFO:0008589) |
PMID:34610981 |
None Available | GCST90091710 | Postprandial free cholesterol in medium LDL | null | C | 0.162323441 | 7E-25 | 24.155 | rs429358 | 0.296131 | free cholesterol measurement (EFO:0008591) low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091711 | Postprandial total lipids in medium LDL | null | C | 0.162323441 | 1E-24 | 24 | rs429358 | 0.295134 | low density lipoprotein cholesterol measurement (EFO:0004611) lipid measurement (EFO:0004529) |
PMID:34610981 |
None Available | GCST90091712 | Postprandial medium LDL particle concentration | null | C | 0.162323441 | 2E-24 | 23.699 | rs429358 | 0.294126 | low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091709 | Postprandial cholesterol esters in medium LDL | null | C | 0.162323441 | 3E-24 | 23.523 | rs429358 | 0.292372 | esterified cholesterol measurement (EFO:0008589) low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091637 | Fasting free cholesterol in very small VLDL | null | C | 0.161800085 | 2E-17 | 16.699 | rs429358 | 0.235239 | free cholesterol measurement (EFO:0008591) very low density lipoprotein cholesterol measurement (EFO:0008317) |
PMID:34610981 |
None Available | GCST90091575 | Fasting monounsaturated fatty acids (16:1, 18:1) | null | C | 0.161676923 | 5E-13 | 12.302 | rs429358 | 0.201189 | fatty acid measurement (EFO:0005110) |
PMID:34610981 |
None Available | GCST90091576 | Fasting total cholesterol in medium VLDL | null | C | 0.161657082 | 1E-12 | 12 | rs429358 | 0.196782 | very low density lipoprotein cholesterol measurement (EFO:0008317) |
PMID:34610981 |
None Available | GCST90091577 | Fasting cholesterol esters in medium VLDL | null | C | 0.161657082 | 9E-15 | 14.046 | rs429358 | 0.21437 | very low density lipoprotein cholesterol measurement (EFO:0008317) esterified cholesterol measurement (EFO:0008589) |
PMID:34610981 |
None Available | GCST90091767 | Postprandial triglycerides levels in very large HDL | null | C | 0.161841572 | 6E-12 | 11.222 | rs429358 | 0.203111 | triglyceride measurement (EFO:0004530) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:34610981 |
None Available | GCST90091688 | Postprandial cholesterol esters in large LDL | null | C | 0.162286109 | 3E-25 | 24.523 | rs429358 | 0.298956 | esterified cholesterol measurement (EFO:0008589) low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091745 | Postprandial total cholesterol in small VLDL | null | C | 0.162286109 | 1E-16 | 16 | rs429358 | 0.238085 | very low density lipoprotein cholesterol measurement (EFO:0008317) |
PMID:34610981 |
None Available | GCST90091714 | Postprandial triglycerides levels in medium LDL | null | C | 0.162323441 | 5E-9 | 8.302 | rs429358 | 0.169359 | low density lipoprotein triglyceride measurement (EFO:0009946) |
PMID:34610981 |
None Available | GCST90091713 | Postprandial phospholipid levels in medium LDL | null | C | 0.162323441 | 1E-25 | 25 | rs429358 | 0.301564 | low density lipoprotein cholesterol measurement (EFO:0004611) phospholipid measurement (EFO:0004639) |
PMID:34610981 |
None Available | GCST90091638 | Fasting total lipids in very small VLDL | null | C | 0.161800085 | 2E-19 | 18.699 | rs429358 | 0.248816 | very low density lipoprotein cholesterol measurement (EFO:0008317) lipid measurement (EFO:0004529) |
PMID:34610981 |
None Available | GCST90091613 | Fasting total fatty acids | null | C | 0.161537304 | 4E-17 | 16.398 | rs429358 | 0.23343 | fatty acid measurement (EFO:0005110) |
PMID:34610981 |
None Available | GCST90091570 | Fasting free cholesterol in medium LDL | null | C | 0.161622913 | 4E-27 | 26.398 | rs429358 | 0.297518 | free cholesterol measurement (EFO:0008591) low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091758 | Postprandial total cholesterol in VLDL | null | C | 0.162286109 | 4E-15 | 14.398 | rs429358 | 0.226902 | total cholesterol measurement (EFO:0004574) very low density lipoprotein cholesterol measurement (EFO:0008317) |
PMID:34610981 |
None Available | GCST90091689 | Postprandial free cholesterol in large LDL | null | C | 0.162286109 | 2E-19 | 18.699 | rs429358 | 0.259943 | free cholesterol measurement (EFO:0008591) low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091687 | Postprandial total cholesterol in large LDL | null | C | 0.162286109 | 6E-24 | 23.222 | rs429358 | 0.290593 | low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091738 | Postprandial cholesterol esters in small LDL | null | C | 0.162323441 | 3E-23 | 22.523 | rs429358 | 0.285996 | esterified cholesterol measurement (EFO:0008589) low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091603 | Fasting triglycerides levels in small LDL | null | C | 0.161585113 | 4E-14 | 13.398 | rs429358 | 0.20887 | low density lipoprotein triglyceride measurement (EFO:0009946) |
PMID:34610981 |
None Available | GCST90091508 | Fasting apolipoprotein B | null | C | 0.161731728 | 6E-26 | 25.222 | rs429358 | 0.290338 | apolipoprotein B measurement (EFO:0004615) |
PMID:34610981 |
None Available | GCST90091618 | Fasting total cholesterol in VLDL | null | C | 0.161731728 | 7E-17 | 16.155 | rs429358 | 0.230802 | total cholesterol measurement (EFO:0004574) very low density lipoprotein cholesterol measurement (EFO:0008317) |
PMID:34610981 |
None Available | GCST90091672 | Postprandial phospholipid levels in IDL | null | C | 0.162360792 | 2E-19 | 18.699 | rs429358 | 0.259683 | phospholipid measurement (EFO:0004639) intermediate density lipoprotein measurement (EFO:0008595) |
PMID:34610981 |
None Available | GCST90091673 | Postprandial triglycerides levels in IDL | null | C | 0.162360792 | 2E-12 | 11.699 | rs429358 | 0.203331 | triglyceride measurement (EFO:0004530) intermediate density lipoprotein measurement (EFO:0008595) |
PMID:34610981 |
None Available | GCST90091690 | Postprandial total lipids in large LDL | null | C | 0.162286109 | 2E-23 | 22.699 | rs429358 | 0.287575 | low density lipoprotein cholesterol measurement (EFO:0004611) lipid measurement (EFO:0004529) |
PMID:34610981 |
None Available | GCST90091739 | Postprandial free cholesterol in small LDL | null | C | 0.162323441 | 4E-24 | 23.398 | rs429358 | 0.291267 | free cholesterol measurement (EFO:0008591) low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091740 | Postprandial total lipids in small LDL | null | C | 0.162323441 | 3E-24 | 23.523 | rs429358 | 0.292 | low density lipoprotein cholesterol measurement (EFO:0004611) lipid measurement (EFO:0004529) |
PMID:34610981 |
None Available | GCST90091605 | Fasting total cholesterol in small VLDL | null | C | 0.161548128 | 4E-18 | 17.398 | rs429358 | 0.240037 | very low density lipoprotein cholesterol measurement (EFO:0008317) |
PMID:34610981 |
None Available | GCST90091512 | Fasting esterified cholesterol | null | C | 0.161711832 | 2E-22 | 21.699 | rs429358 | 0.26976 | esterified cholesterol measurement (EFO:0008589) |
PMID:34610981 |
None Available | GCST90091536 | Fasting total cholesterol in LDL | null | C | 0.161731728 | 1E-25 | 25 | rs429358 | 0.288192 | total cholesterol measurement (EFO:0004574) low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091776 | Postprandial cholesterol esters in very small VLDL | null | C | 0.162323441 | 1E-21 | 21 | rs429358 | 0.275209 | very low density lipoprotein cholesterol measurement (EFO:0008317) esterified cholesterol measurement (EFO:0008589) |
PMID:34610981 |
None Available | GCST90091777 | Postprandial free cholesterol in very small VLDL | null | C | 0.162323441 | 2E-18 | 17.699 | rs429358 | 0.25234 | free cholesterol measurement (EFO:0008591) very low density lipoprotein cholesterol measurement (EFO:0008317) |
PMID:34610981 |
None Available | GCST90091775 | Postprandial total cholesterol in very small VLDL | null | C | 0.162323441 | 3E-21 | 20.523 | rs429358 | 0.272445 | very low density lipoprotein cholesterol measurement (EFO:0008317) |
PMID:34610981 |
None Available | GCST90091675 | Postprandial linoleic acid (18:2) | null | C | 0.162416939 | 2E-18 | 17.699 | rs429358 | 0.254613 | linoleic acid measurement (EFO:0006807) |
PMID:34610981 |
None Available | GCST90091691 | Postprandial large LDL particle concentration | null | C | 0.162286109 | 1E-23 | 23 | rs429358 | 0.288742 | low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091726 | Postprandial remnant cholesterol | null | C | 0.162286109 | 3E-23 | 22.523 | rs429358 | 0.285465 | remnant cholesterol measurement (EFO:0010815) |
PMID:34610981 |
None Available | GCST90091727 | Postprandial serum total cholesterol | null | C | 0.162286109 | 5E-19 | 18.302 | rs429358 | 0.256825 | total cholesterol measurement (EFO:0004574) |
PMID:34610981 |
None Available | GCST90091606 | Fasting cholesterol esters in small VLDL | null | C | 0.161548128 | 7E-19 | 18.155 | rs429358 | 0.245388 | very low density lipoprotein cholesterol measurement (EFO:0008317) esterified cholesterol measurement (EFO:0008589) |
PMID:34610981 |
None Available | GCST90091516 | Fasting free cholesterol | null | C | 0.161722328 | 9E-18 | 17.046 | rs429358 | 0.237671 | free cholesterol measurement (EFO:0008591) |
PMID:34610981 |
None Available | GCST90091515 | Fasting omega-6 fatty acids | null | C | 0.16165072 | 1E-20 | 20 | rs429358 | 0.257377 | omega-6 polyunsaturated fatty acid measurement (EFO:0005680) |
PMID:34610981 |
None Available | GCST90091538 | Fasting triglycerides in LDL | null | C | 0.161731728 | 4E-13 | 12.398 | rs429358 | 0.200855 | low density lipoprotein triglyceride measurement (EFO:0009946) |
PMID:34610981 |
None Available | GCST90091778 | Postprandial total lipids in very small VLDL | null | C | 0.162323441 | 2E-21 | 20.699 | rs429358 | 0.273218 | very low density lipoprotein cholesterol measurement (EFO:0008317) lipid measurement (EFO:0004529) |
PMID:34610981 |
None Available | GCST90091779 | Postprandial very small VLDL particle concentration | null | C | 0.162323441 | 7E-21 | 20.155 | rs429358 | 0.270037 | very low density lipoprotein cholesterol measurement (EFO:0008317) |
PMID:34610981 |
None Available | GCST90091692 | Postprandial phospholipid levels in large LDL | null | C | 0.162286109 | 8E-23 | 22.097 | rs429358 | 0.282984 | low density lipoprotein cholesterol measurement (EFO:0004611) phospholipid measurement (EFO:0004639) |
PMID:34610981 |
None Available | GCST90091607 | Fasting free cholesterol in small VLDL | null | C | 0.161548128 | 3E-14 | 13.523 | rs429358 | 0.20992 | free cholesterol measurement (EFO:0008591) very low density lipoprotein cholesterol measurement (EFO:0008317) |
PMID:34610981 |
None Available | GCST90091650 | Postprandial apolipoprotein B | null | C | 0.162286109 | 9E-23 | 22.046 | rs429358 | 0.28278 | apolipoprotein B measurement (EFO:0004615) |
PMID:34610981 |
None Available | GCST90091655 | Postprandial esterified cholesterol | null | C | 0.16245049 | 5E-19 | 18.302 | rs429358 | 0.258516 | esterified cholesterol measurement (EFO:0008589) |
PMID:34610981 |
None Available | GCST90091780 | Postprandial phospholipid levels in very small VLDL | null | C | 0.162323441 | 1E-19 | 19 | rs429358 | 0.26193 | very low density lipoprotein cholesterol measurement (EFO:0008317) phospholipid measurement (EFO:0004639) |
PMID:34610981 |
None Available | GCST90091693 | Postprandial triglycerides levels in large LDL | null | C | 0.162286109 | 5E-11 | 10.302 | rs429358 | 0.189325 | low density lipoprotein triglyceride measurement (EFO:0009946) |
PMID:34610981 |
None Available | GCST90091729 | Postprandial saturated fatty acids | null | C | 0.162437075 | 7E-10 | 9.155 | rs429358 | 0.179498 | fatty acid measurement (EFO:0005110) |
PMID:34610981 |
None Available | GCST90091667 | Postprandial total cholesterol in IDL | null | C | 0.162360792 | 2E-23 | 22.699 | rs429358 | 0.287255 | intermediate density lipoprotein measurement (EFO:0008595) |
PMID:34610981 |
None Available | GCST90091668 | Postprandial cholesterol esters in IDL | null | C | 0.162360792 | 1E-25 | 25 | rs429358 | 0.300889 | esterified cholesterol measurement (EFO:0008589) intermediate density lipoprotein measurement (EFO:0008595) |
PMID:34610981 |
None Available | GCST90091659 | Postprandial free cholesterol | null | C | 0.162419911 | 5E-16 | 15.302 | rs429358 | 0.23526 | free cholesterol measurement (EFO:0008591) |
PMID:34610981 |
None Available | GCST90091658 | Postprandial omega-6 fatty acids | null | C | 0.162416939 | 5E-18 | 17.302 | rs429358 | 0.250807 | omega-6 polyunsaturated fatty acid measurement (EFO:0005680) |
PMID:34610981 |
None Available | GCST90091526 | Fasting total cholesterol in IDL | null | C | 0.161479805 | 2E-24 | 23.699 | rs429358 | 0.281504 | intermediate density lipoprotein measurement (EFO:0008595) |
PMID:34610981 |
None Available | GCST90091676 | Postprandial total cholesterol in LDL | null | C | 0.162286109 | 3E-24 | 23.523 | rs429358 | 0.291885 | total cholesterol measurement (EFO:0004574) low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091597 | Fasting total cholesterol in small LDL | null | C | 0.161585113 | 5E-26 | 25.302 | rs429358 | 0.291323 | low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091598 | Fasting cholesterol esters in small LDL | null | C | 0.161585113 | 1E-25 | 25 | rs429358 | 0.289353 | esterified cholesterol measurement (EFO:0008589) low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091639 | Fasting very small VLDL particle concentration | null | C | 0.161800085 | 3E-19 | 18.523 | rs429358 | 0.247981 | very low density lipoprotein cholesterol measurement (EFO:0008317) |
PMID:34610981 |
None Available | GCST90091532 | Fasting triglycerides levels in IDL | null | C | 0.161479805 | 1E-12 | 12 | rs429358 | 0.196548 | triglyceride measurement (EFO:0004530) intermediate density lipoprotein measurement (EFO:0008595) |
PMID:34610981 |
None Available | GCST90091531 | Fasting phospholipid levels in IDL | null | C | 0.161479805 | 4E-21 | 20.398 | rs429358 | 0.260746 | phospholipid measurement (EFO:0004639) intermediate density lipoprotein measurement (EFO:0008595) |
PMID:34610981 |
None Available | GCST90091534 | Fasting linoleic acid (18:2) | null | C | 0.161647532 | 3E-22 | 21.523 | rs429358 | 0.268282 | linoleic acid measurement (EFO:0006807) |
PMID:34610981 |
None Available | GCST90091527 | Fasting cholesterol esters in IDL | null | C | 0.161479805 | 8E-26 | 25.097 | rs429358 | 0.290188 | esterified cholesterol measurement (EFO:0008589) intermediate density lipoprotein measurement (EFO:0008595) |
PMID:34610981 |
None Available | GCST90091753 | Postprandial total fatty acids | null | C | 0.162371642 | 4E-13 | 12.398 | rs429358 | 0.210999 | fatty acid measurement (EFO:0005110) |
PMID:34610981 |
None Available | GCST90091599 | Fasting free cholesterol in small LDL | null | C | 0.161585113 | 9E-27 | 26.046 | rs429358 | 0.295596 | free cholesterol measurement (EFO:0008591) low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091589 | Fasting saturated fatty acids | null | C | 0.161711477 | 1E-12 | 12 | rs429358 | 0.197394 | fatty acid measurement (EFO:0005110) |
PMID:34610981 |
None Available | GCST90091669 | Postprandial free cholesterol in IDL | null | C | 0.162360792 | 4E-17 | 16.398 | rs429358 | 0.242738 | free cholesterol measurement (EFO:0008591) intermediate density lipoprotein measurement (EFO:0008595) |
PMID:34610981 |
None Available | GCST90091670 | Postprandial total lipids in IDL | null | C | 0.162286109 | 6E-23 | 22.222 | rs429358 | 0.283672 | lipid measurement (EFO:0004529) intermediate density lipoprotein measurement (EFO:0008595) |
PMID:34610981 |
None Available | GCST90091640 | Fasting phospholipid levels in very small VLDL | null | C | 0.161800085 | 2E-18 | 17.699 | rs429358 | 0.241817 | very low density lipoprotein cholesterol measurement (EFO:0008317) phospholipid measurement (EFO:0004639) |
PMID:34610981 |
None Available | GCST90091528 | Fasting free cholesterol in IDL | null | C | 0.161479805 | 5E-20 | 19.302 | rs429358 | 0.253317 | free cholesterol measurement (EFO:0008591) intermediate density lipoprotein measurement (EFO:0008595) |
PMID:34610981 |
None Available | GCST90091529 | Fasting total lipids in IDL | null | C | 0.161731728 | 6E-23 | 22.222 | rs429358 | 0.272217 | lipid measurement (EFO:0004529) intermediate density lipoprotein measurement (EFO:0008595) |
PMID:34610981 |
None Available | GCST90091530 | Fasting IDL particle concentration | null | C | 0.161731728 | 3E-23 | 22.523 | rs429358 | 0.273934 | intermediate density lipoprotein measurement (EFO:0008595) |
PMID:34610981 |
None Available | GCST90091568 | Fasting total cholesterol in medium LDL | null | C | 0.161622913 | 2E-26 | 25.699 | rs429358 | 0.29323 | low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091569 | Fasting cholesterol esters in medium LDL | null | C | 0.161622913 | 4E-26 | 25.398 | rs429358 | 0.291486 | esterified cholesterol measurement (EFO:0008589) low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091678 | Postprandial triglycerides in LDL | null | C | 0.162286109 | 4E-11 | 10.398 | rs429358 | 0.19086 | low density lipoprotein triglyceride measurement (EFO:0009946) |
PMID:34610981 |
None Available | GCST90091746 | Postprandial cholesterol esters in small VLDL | null | C | 0.162286109 | 4E-19 | 18.398 | rs429358 | 0.257337 | very low density lipoprotein cholesterol measurement (EFO:0008317) esterified cholesterol measurement (EFO:0008589) |
PMID:34610981 |
None Available | GCST90091715 | Postprandial monounsaturated fatty acids (16:1, 18:1) | null | C | 0.162399016 | 6E-9 | 8.222 | rs429358 | 0.16938 | fatty acid measurement (EFO:0005110) |
PMID:34610981 |
None Available | GCST90091571 | Fasting total lipids in medium LDL | null | C | 0.161622913 | 9E-27 | 26.046 | rs429358 | 0.295396 | low density lipoprotein cholesterol measurement (EFO:0004611) lipid measurement (EFO:0004529) |
PMID:34610981 |
None Available | GCST90091747 | Postprandial free cholesterol in small VLDL | null | C | 0.162286109 | 6E-11 | 10.222 | rs429358 | 0.188943 | free cholesterol measurement (EFO:0008591) very low density lipoprotein cholesterol measurement (EFO:0008317) |
PMID:34610981 |
None Available | GCST90091748 | Postprandial total lipids in small VLDL | null | C | 0.162286109 | 1E-10 | 10 | rs429358 | 0.185288 | very low density lipoprotein cholesterol measurement (EFO:0008317) lipid measurement (EFO:0004529) |
PMID:34610981 |
None Available | GCST90091595 | Fasting phospholipid levels in small HDL | null | C | 0.161366928 | 2E-13 | 12.699 | rs429358 | 0.203946 | phospholipid measurement (EFO:0004639) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:34610981 |
None Available | GCST90091550 | Fasting total lipids in large LDL | null | C | 0.161731728 | 9E-25 | 24.046 | rs429358 | 0.283473 | low density lipoprotein cholesterol measurement (EFO:0004611) lipid measurement (EFO:0004529) |
PMID:34610981 |
None Available | GCST90091572 | Fasting medium LDL particle concentration | null | C | 0.161622913 | 9E-27 | 26.046 | rs429358 | 0.295573 | low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091749 | Postprandial small VLDL particle concentration | null | C | 0.162286109 | 7E-10 | 9.155 | rs429358 | 0.17839 | very low density lipoprotein cholesterol measurement (EFO:0008317) |
PMID:34610981 |
None Available | GCST90091750 | Postprandial phospholipid levels in small VLDL | null | C | 0.162286109 | 3E-9 | 8.523 | rs429358 | 0.171262 | very low density lipoprotein cholesterol measurement (EFO:0008317) phospholipid measurement (EFO:0004639) |
PMID:34610981 |
None Available | GCST90091717 | Postprandial cholesterol esters in medium VLDL | null | C | 0.162286109 | 3E-13 | 12.523 | rs429358 | 0.210906 | very low density lipoprotein cholesterol measurement (EFO:0008317) esterified cholesterol measurement (EFO:0008589) |
PMID:34610981 |
None Available | GCST90091716 | Postprandial total cholesterol in medium VLDL | null | C | 0.162286109 | 2E-10 | 9.699 | rs429358 | 0.184361 | very low density lipoprotein cholesterol measurement (EFO:0008317) |
PMID:34610981 |
None Available | GCST90091547 | Fasting total cholesterol in large LDL | null | C | 0.161731728 | 5E-25 | 24.302 | rs429358 | 0.285202 | low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091551 | Fasting large LDL particle concentration | null | C | 0.161731728 | 6E-25 | 24.222 | rs429358 | 0.284538 | low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091549 | Fasting free cholesterol in large LDL | null | C | 0.161731728 | 1E-21 | 21 | rs429358 | 0.264058 | free cholesterol measurement (EFO:0008591) low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091548 | Fasting cholesterol esters in large LDL | null | C | 0.161731728 | 3E-26 | 25.523 | rs429358 | 0.29202 | esterified cholesterol measurement (EFO:0008589) low density lipoprotein cholesterol measurement (EFO:0004611) |
PMID:34610981 |
None Available | GCST90091735 | Postprandial phospholipid levels in small HDL | null | C | 0.162158672 | 6E-17 | 16.222 | rs429358 | 0.241174 | phospholipid measurement (EFO:0004639) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:34610981 |
None Available | GCST90091579 | Fasting total lipids in medium VLDL | null | C | 0.161657082 | 5E-10 | 9.302 | rs429358 | 0.172049 | very low density lipoprotein cholesterol measurement (EFO:0008317) lipid measurement (EFO:0004529) |
PMID:34610981 |
None Available | GCST90091578 | Fasting free cholesterol in medium VLDL | null | C | 0.161657082 | 4E-10 | 9.398 | rs429358 | 0.173567 | free cholesterol measurement (EFO:0008591) very low density lipoprotein cholesterol measurement (EFO:0008317) |
PMID:34610981 |
None Available | GCST90091580 | Fasting medium VLDL particle concentration | null | C | 0.161657082 | 9E-10 | 9.046 | rs429358 | 0.169589 | very low density lipoprotein cholesterol measurement (EFO:0008317) |
PMID:34610981 |
None Available | GCST90091581 | Fasting phospholipid levels in medium VLDL | null | C | 0.161657082 | 8E-11 | 10.097 | rs429358 | 0.179834 | very low density lipoprotein cholesterol measurement (EFO:0008317) phospholipid measurement (EFO:0004639) |
PMID:34610981 |
None Available | GCST90091627 | Fasting triglycerides levels in very large HDL | null | C | 0.160012675 | 9E-13 | 12.046 | rs429358 | 0.201575 | triglyceride measurement (EFO:0004530) high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:34610981 |
None Available | GCST90091553 | Fasting triglycerides levels in large LDL | null | C | 0.161731728 | 1E-12 | 12 | rs429358 | 0.195889 | low density lipoprotein triglyceride measurement (EFO:0009946) |
PMID:34610981 |
None Available | GCST90091552 | Fasting phospholipid levels in large LDL | null | C | 0.161731728 | 4E-24 | 23.398 | rs429358 | 0.279787 | low density lipoprotein cholesterol measurement (EFO:0004611) phospholipid measurement (EFO:0004639) |
PMID:34610981 |
None Available | GCST90002404 | Red cell distribution width | 408,112 British individuals | C | 0.154472 | 2E-59 | 58.699 | rs429358 | 0.050305303 | Red cell distribution width (EFO:0009188) |
PMID:32888494 |
None Available | GCST90446535 | Cardiovascular disease | 44,238 European ancestry cases, 414,900 European ancestry controls | ? | NR | 3E-19 | 18.523 | rs429358 | N/A | cardiovascular disease (EFO:0000319) |
PMID:37947095 |
None Available | GCST90446655 | Fall | 20,789 European ancestry cases, 180,658 European ancestry controls | C | NR | 4E-9 | 8.398 | rs429358 | 0.085 | fall (EFO:0009631) |
PMID:37945700 |
None Available | GCST90448094 | Age-related macular degeneration | 2,123 European ancestry cases, 2,704 European ancestry controls | ? | NR | 9E-26 | 25.046 | rs429358 | 0.513 | age-related macular degeneration (EFO:0001365) |
PMID:37975850 |
None Available | GCST90446533 | Angina | 25,257 European ancestry cases, 433,881 European ancestry controls | ? | NR | 2E-16 | 15.699 | rs429358 | N/A | angina pectoris (EFO:0003913) |
PMID:37947095 |
None Available | GCST90448456 | Memory decline in normal cognition | 7,839 European ancestry females, 1,384 African ancestry females | ? | NR | 6E-21 | 20.222 | rs429358 | 0.015197 | memory performance (EFO:0004874) |
PMID:37984853 |
None Available | GCST90448418 | Baseline memory | 11,062 European ancestry males, 880 African ancestry males | ? | NR | 2E-14 | 13.699 | rs429358 | 0.129137 | memory performance (EFO:0004874) |
PMID:37984853 |
None Available | GCST90448434 | Baseline memory in impaired cognition | 3,987 European ancestry females | ? | NR | 1E-19 | 19 | rs429358 | 0.325115 | memory performance (EFO:0004874) |
PMID:37984853 |
None Available | GCST90448451 | Memory decline | 11,062 European ancestry males | ? | NR | 1E-27 | 27 | rs429358 | 0.019976 | memory performance (EFO:0004874) |
PMID:37984853 |
None Available | GCST90448462 | Memory decline in normal cognition | 7,839 European ancestry females | ? | NR | 3E-20 | 19.523 | rs429358 | 0.015817 | memory performance (EFO:0004874) |
PMID:37984853 |
None Available | GCST90448452 | Memory decline in impaired cognition | 4,478 European ancestry males | ? | NR | 1E-17 | 17 | rs429358 | 0.048454 | memory performance (EFO:0004874) |
PMID:37984853 |
None Available | GCST90448424 | Baseline memory | 11,062 European ancestry males | ? | NR | 6E-14 | 13.222 | rs429358 | 0.131 | memory performance (EFO:0004874) |
PMID:37984853 |
None Available | GCST90448460 | Memory decline | 13,154 European ancestry females | ? | NR | 6E-33 | 32.222 | rs429358 | 0.019882 | memory performance (EFO:0004874) |
PMID:37984853 |
None Available | GCST90448454 | Memory decline | 13,154 European ancestry females, 2,487 African ancestry females | ? | NR | 6E-35 | 34.222 | rs429358 | 0.019133 | memory performance (EFO:0004874) |
PMID:37984853 |
None Available | GCST90448427 | Baseline memory | 13,154 European ancestry females, 2,487 African ancestry females | ? | NR | 4E-20 | 19.398 | rs429358 | 0.123151 | memory performance (EFO:0004874) |
PMID:37984853 |
None Available | GCST90448425 | Baseline memory in impaired cognition | 4,478 European ancestry males | ? | NR | 5E-11 | 10.302 | rs429358 | 0.206475 | memory performance (EFO:0004874) |
PMID:37984853 |
None Available | GCST90448433 | Baseline memory | 13,154 European ancestry females | ? | NR | 7E-20 | 19.155 | rs429358 | 0.134697 | memory performance (EFO:0004874) |
PMID:37984853 |
None Available | GCST90448447 | Memory decline in normal cognition | 4,950 European ancestry males, 391 African ancestry males | ? | NR | 9E-13 | 12.046 | rs429358 | 0.013374 | memory performance (EFO:0004874) |
PMID:37984853 |
None Available | GCST90428121 | Whole body fat mass (UKB data field 23100) | 337,196 European ancestry individuals | C | NR | 5E-10 | 9.302 | rs429358 | 0.0203752 | fat body mass (EFO:0005409) |
PMID:38538606 |
None Available | GCST90448453 | Memory decline in normal cognition | 4,950 European ancestry males | ? | NR | 2E-13 | 12.699 | rs429358 | 0.01405 | memory performance (EFO:0004874) |
PMID:37984853 |
None Available | GCST90448604 | C-reactive protein levels | 38,000 South Asian ancestry individuals | C | NR | 1E-39 | 39 | rs429358 | 0.187 | C-reactive protein measurement (EFO:0004458) |
PMID:39414775 |
None Available | GCST90448445 | Memory decline | 11,062 European ancestry males, 880 African ancestry males | ? | NR | 2E-26 | 25.699 | rs429358 | 0.018969 | memory performance (EFO:0004874) |
PMID:37984853 |
None Available | GCST90448615 | HDL cholesterol levels | 38,000 South Asian ancestry individuals | C | NR | 2E-50 | 49.699 | rs429358 | 0.169 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:39414775 |
Database | Acc Id | Source(s) |
GWAS Catalog | GCST90092894 | GWAS Catalog |
GCST90269633 | GWAS Catalog |
Note Type | Note | Reference |
---|